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Abstract	  
	   Prescription	  opioid	  analgesics	  have	  been	  implicated	  as	  a	  contributing	  factor	  in	  the	  precipitous	  rise	  in	  unintentional	  poisonings	  in	  North	  Carolina	  over	  the	  past	  decade1,2.	  	  Epidemiological	  data	  suggest	  that	  the	  recent	  rise	  in	  unintentional	  poisonings	  is	  associated	  with	  a	  corresponding	  increase	  in	  the	  sale	  of	  opioid	  analgesics3.	  	  A	  literature	  review	  was	  conducted	  to	  evaluate	  the	  status	  of	  intervention	  programs	  that	  address	  the	  factors	  thought	  to	  be	  associated	  with	  opioid	  overdose	  and	  inform	  elements	  of	  a	  program	  to	  reduce	  mortality.	  	  	  In	  this	  paper	  I	  present	  an	  evidence-­‐based	  program	  and	  evaluation	  plan	  that	  combines	  elements	  from	  the	  literature	  that	  were	  found	  to	  reduce	  overdose	  mortality.	  	  	  The	  plan	  emphasizes	  primary	  prevention	  through	  community	  involvement,	  physician	  education,	  uniform	  opioid	  prescribing	  guidelines,	  and	  modification	  of	  emergency	  department	  prescribing	  policies.	  	  Secondary	  and	  tertiary	  prevention	  components	  of	  the	  plan	  include	  increased	  use	  of	  the	  Controlled	  Substance	  Reporting	  System,	  the	  use	  of	  universal	  safety	  precautions,	  and	  distribution	  of	  Naloxone	  “rescue	  kits”	  to	  high-­‐risk	  patients.	  	  Implementation	  of	  the	  plan	  requires	  the	  development	  of	  a	  community	  coalition	  at	  the	  county	  level,	  consisting	  of	  representatives	  from	  the	  local	  health	  department,	  physicians,	  hospitals,	  and	  other	  stakeholders.	  Strong	  leadership	  on	  the	  part	  of	  the	  coalition	  is	  crucial	  to	  achieving	  successful	  outcomes.	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Introduction	  
Abuse	  and	  improper	  use	  of	  extended	  release	  and	  long	  acting	  prescription	  opioid	  analgesics	  have	  resulted	  in	  an	  epidemic	  of	  addiction,	  overdose	  and	  death4.	  Poisoning	  is	  the	  second	  leading	  cause	  of	  unintentional	  death	  in	  North	  Carolina,	  and	  the	  leading	  cause	  of	  injury	  death	  in	  the	  United	  States,	  exceeding	  death	  from	  motor	  vehicle	  accidents1,5,6.	  	  	  Opioid	  analgesics,	  such	  as	  methadone,	  fentanyl,	  hydrocodone,	  and	  oxycodone,	  are	  the	  most	  common	  causes	  of	  unintentional	  poisoning,	  accounting	  for	  nearly	  74%	  of	  cases7.	  	   The	  rate	  of	  unintentional	  poisoning	  in	  North	  Carolina	  averaged	  11.3	  deaths	  (95%	  CI:	  10.6	  –	  12.0)	  per	  100,000	  residents	  during	  2012.	  	  However,	  the	  rate	  varied	  by	  nearly	  an	  order	  of	  magnitude	  among	  the	  100	  North	  Carolina	  counties:	  	  the	  lowest	  rate	  in	  the	  state	  was	  recorded	  in	  Union	  County	  (4.1,	  95%	  CI	  2.5-­‐5.7),	  while	  the	  highest	  rate	  was	  observed	  in	  Cherokee	  County	  (36.8,	  95%	  CI	  23.6-­‐49.9).	  	  Chowan	  and	  Jones	  Counties	  did	  not	  report	  any	  unintentional	  poisoning	  deaths	  in	  2012.	  	  Demographically,	  the	  majority	  of	  overdose	  victims	  in	  North	  Carolina	  are	  male	  (63%),	  European	  American,	  and	  between	  the	  ages	  of	  20-­‐54	  (86%)1.	  	  Additional	  host	  factors	  include	  low	  socioeconomic	  status	  and	  mental	  health	  problems3.	  	  These	  demographic	  characteristics	  are	  consistent	  with	  demographic	  studies	  of	  overdose	  victims	  in	  other	  states2.	  	  	  Agent	  and	  environmental	  factors	  include:	  (1)	  use	  of	  opioid	  analgesics	  and	  benzodiazepines;	  (2)	  high	  prescribed	  dosage	  for	  opioid	  analgesics;	  (3)	  multiple	  prescriptions;	  (4)	  multiple	  prescribers;	  (5)	  rural	  residence;	  and	  	  (6)	  high	  community	  prescribing	  rates3.	  	  	   Numerous	  strategies	  have	  been	  developed	  to	  address	  mortality	  associated	  with	  opioid	  analgesics.	  	  Yet,	  physicians	  often	  receive	  little	  education	  on	  safe	  prescribing	  practices	  for	  opioids,	  and	  often	  dispense	  these	  medications	  to	  patients	  without	  knowledge	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of	  the	  risks	  and	  benefits	  of	  opioid	  pain	  therapy8.	  	  Responsible	  opioid	  prescribing	  practices	  can	  inform	  educational	  programs	  for	  providers	  that	  emphasize	  better	  patient	  evaluation,	  treatment	  plans,	  periodic	  reviews,	  and	  patient	  education.	  	  Diversion	  –	  the	  use	  of	  opioid	  medications	  for	  non-­‐medical	  use	  –	  and	  “doctor	  shopping”	  –	  the	  practice	  whereby	  patients	  seek	  prescription	  medications	  from	  multiple	  providers	  –	  are	  a	  significant	  source	  of	  opioid	  abuse.	  	  	  Prescription	  drug	  monitoring	  programs,	  such	  as	  the	  North	  Carolina	  Controlled	  Substance	  Reporting	  System,	  enable	  providers	  to	  review	  their	  patients’	  prescription	  history	  and	  intervene	  where	  appropriate.	  	  	  Recently	  enacted	  legislation	  mandating	  participation	  in	  the	  CSRS	  beginning	  in	  2014	  raises	  the	  prospect	  for	  improved	  utilization	  of	  this	  tool9.	  	  Outpatient	  substance	  abuse	  treatment	  programs,	  and	  harm	  reduction	  interventions	  are	  examples	  of	  secondary	  and	  tertiary	  preventions	  that	  offer	  the	  potential	  for	  reducing	  mortality.	  	   Based	  on	  a	  review	  of	  the	  available	  literature	  I	  have	  developed	  a	  community-­‐based	  program	  and	  evaluation	  plan	  designed	  for	  implementation	  by	  a	  local	  health	  department.	  	  The	  goal	  of	  the	  plan	  is	  to	  reduce	  the	  incidence	  of	  overdose	  mortality	  through	  a	  multi-­‐level,	  bottom-­‐up	  approach	  that	  incorporates	  education,	  policy	  modification,	  and	  community	  involvement.	  	  The	  first	  section	  of	  this	  paper	  describes	  the	  results	  of	  a	  systematic	  review	  of	  the	  literature	  to	  identify	  existing	  opioid	  overdose	  mortality	  reduction	  programs.	  	  The	  second	  section	  of	  the	  paper	  consists	  of	  a	  program	  plan	  that	  describes	  the	  context,	  relevant	  theories,	  program	  goals,	  logic	  model,	  detailed	  implementation	  plan,	  and	  a	  budget	  estimate	  for	  the	  program.	  	  The	  third	  section	  of	  the	  paper	  describes	  the	  evaluation	  plan,	  which	  provides	  a	  mechanism	  to	  measure	  the	  effectiveness	  of	  the	  program.	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Systematic	  Review	  
Introduction	  	   I	  conducted	  a	  systematic	  review	  to	  identify	  programs	  similar	  to	  Project	  Lazarus	  that	  addressed	  opioid	  overdose	  prevention10.	  	  The	  programs	  targeted	  in	  the	  review	  contained	  the	  five	  basic	  components	  of	  the	  Lazarus	  program:	  1. Community	  activation	  and	  coalition	  building;	  2. Monitoring	  and	  surveillance	  data;	  3. Prevention	  of	  overdoses;	  4. Use	  of	  rescue	  medication	  for	  reversing	  overdoses	  by	  community	  members;	  5. Evaluating	  project	  components.	  The	  results	  of	  the	  review	  will	  inform	  development	  of	  a	  multi-­‐level,	  evidence	  based	  intervention	  plan	  and	  evaluation	  strategy.	  
Methods	  
Research	  Question	  	   I	  conducted	  a	  literature	  search	  and	  review	  to	  answer	  the	  primary	  research	  question:	  	  What	  other	  programs	  exist	  which	  employ	  some	  or	  all	  of	  the	  five	  basic	  components	  of	  the	  Project	  Lazarus	  model,	  and	  what	  can	  be	  learned	  from	  the	  outcomes	  to	  assist	  in	  the	  development	  of	  a	  program	  plan	  and	  evaluation	  plan	  for	  my	  proposed	  intervention?	  
Search	  Strategy	  	   I	  employed	  a	  multi-­‐part	  search	  strategy	  of	  the	  scholarly	  literature	  in	  the	  sciences,	  social	  sciences,	  arts,	  and	  humanities.	  The	  terms	  used	  in	  the	  search	  were	  “opioid	  OR	  opioids”	  AND	  “overdose”	  AND	  “physician	  OR	  physicians	  OR	  primary	  care”	  AND	  “education.”	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Two	  databases	  were	  searched:	  	  the	  Web	  of	  Science	  and	  PubMed.	  	  Two	  databases	  were	  selected	  to	  ensure	  the	  widest	  possible	  breadth	  of	  articles	  is	  recovered.	  	  Using	  these	  search	  terms,	  15	  articles	  matching	  the	  search	  criteria	  were	  found	  in	  the	  Web	  of	  Science	  database	  and	  29	  articles	  were	  identified	  in	  the	  PubMed	  database.	  	  A	  Subject	  Matter	  Expert	  (SME)	  from	  Northern	  Piedmont	  Community	  Care,	  who	  is	  currently	  engaged	  in	  an	  opioid	  overdose	  intervention,	  was	  consulted	  to	  assist	  in	  identifying	  relevant	  journal	  articles.	  	  	  	  The	  primary	  article	  identified	  by	  the	  SME	  was	  retrieved,	  and	  was	  found	  to	  have	  been	  cited	  in	  20	  other	  articles.	  	  These	  articles	  were	  retrieved	  and	  evaluated	  for	  relevance	  using	  the	  inclusion	  and	  exclusion	  criteria	  described	  in	  the	  next	  section.	  	  	  
Inclusion	  and	  Exclusion	  Criteria	  	   The	  literature	  review	  included	  programs	  that	  incorporated	  three	  or	  more	  of	  the	  five	  components	  described	  in	  the	  preceding	  section.	  	  I	  further	  narrowed	  the	  list	  of	  relevant	  programs	  for	  review	  by	  including	  these	  criteria:	  1. The	  full	  article	  is	  available	  for	  review	  from	  a	  peer	  reviewed	  journal;	  2. The	  program	  was	  implemented	  or	  is	  currently	  being	  implemented	  in	  the	  United	  States.	  3. The	  program	  must	  have	  been	  implemented	  by	  a	  coalition	  of	  stakeholders,	  not	  simply	  by	  a	  stand-­‐alone	  agency.	  After	  applying	  the	  inclusion	  and	  exclusion	  criteria	  the	  search	  yielded	  a	  total	  of	  five	  programs	  for	  review.	  	  The	  programs	  that	  met	  the	  inclusion	  criteria	  for	  review	  are	  summarized	  in	  Table	  1.	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Summary	  of	  Programs	  
Project	  Lazarus	  Program	  Project	  Lazarus10	  is	  a	  community	  based	  overdose	  prevention	  program	  developed	  in	  response	  to	  a	  poisoning	  mortality	  rate	  in	  Wilkes	  County,	  NC	  more	  than	  four	  times	  higher	  than	  the	  average	  rate	  observed	  in	  North	  Carolina	  (46.6	  vs.	  11.0	  deaths	  per	  100,000	  population	  in	  2009).	  	  The	  components	  of	  the	  intervention	  included	  community-­‐activation	  and	  coalition	  building;	  prescriber	  education	  and	  behavior	  change;	  supply	  reduction	  and	  diversion	  control;	  pain	  patient	  services	  and	  drug	  safety;	  addiction	  treatment	  and	  demand	  reduction;	  harm	  reduction;	  and	  community-­‐based	  prevention	  education.	  	  	  	   The	  developers	  of	  the	  program	  felt	  that	  a	  “bottom-­‐up”	  approach	  to	  the	  design	  and	  implementation	  of	  the	  program	  could	  better	  leverage	  existing	  resources	  and	  raise	  community	  awareness.	  	  The	  community-­‐activation	  component	  of	  the	  program	  was	  informed	  by	  research	  on	  health	  promotion,	  which	  indicated	  that	  the	  most	  important	  organizations	  for	  health	  campaigns	  were	  health	  departments,	  schools,	  government	  agencies,	  hospitals,	  primary	  care	  providers,	  and	  the	  media.	  	  	  Other	  relevant	  organizations	  to	  community-­‐activation	  were	  identified	  as	  television	  stations,	  health	  related	  non-­‐profits,	  substance	  abuse	  centers	  and	  colleges.	  	  Emergent	  leaders	  facilitated	  “activation”	  of	  the	  community	  by	  creating	  specialized	  task-­‐forces,	  chairing	  town	  hall	  meetings,	  fostering	  coalitions	  among	  organizations,	  and	  overseeing	  assembly	  of	  “Managing	  Chronic	  Pain”	  tool	  kits	  used	  as	  part	  of	  the	  intervention.	  	  Project	  Lazarus	  program	  staff	  coordinated	  activities,	  developed	  action	  plans,	  trained	  community	  organizers,	  and	  raised	  awareness	  of	  the	  overdose	  issue.	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   Prescriber	  education	  and	  behavior	  modification	  is	  aimed	  toward	  providing	  primary	  care	  providers	  the	  tools	  they	  need	  ensure	  safe	  and	  effective	  analgesia	  for	  their	  patients	  while	  minimizing	  the	  potential	  harm	  to	  those	  at	  risk	  for	  addiction	  and	  overdose.	  	  The	  project	  achieves	  these	  goals	  in	  part	  by	  providing	  primary	  care	  providers	  one-­‐on-­‐one	  prescriber	  education,	  offering	  guidelines	  for	  responsible	  opioid	  prescribing11,	  creating	  a	  physician’s	  tool	  kit	  for	  chronic	  pain	  management12,	  and	  offering	  continuing	  education	  sessions	  on	  pain	  management.	  	  The	  project	  also	  encourages	  behavioral	  change	  by	  physicians	  by	  sanctioning	  licensing	  action	  against	  prescribers	  who	  prescribe	  opioid	  analgesics	  without	  examination	  and	  evaluation	  of	  patient	  needs.	  	  	  	   The	  North	  Carolina	  Controlled	  Substance	  Reporting	  System	  (CSRS)	  13	  offers	  enrolled	  clinicians	  the	  ability	  to	  identify	  patients	  who	  may	  be	  misusing	  and	  diverting	  prescribed	  medications	  by	  tracking	  the	  distribution	  of	  controlled	  substances.	  	  This	  statewide	  system,	  available	  only	  to	  providers,	  law	  enforcement,	  and	  the	  courts,	  enhances	  the	  ability	  of	  physicians	  to	  identify	  potential	  abuse	  and	  has	  the	  potential	  to	  reduce	  morbidity	  and	  mortality	  from	  overdose.	  	  At	  time	  the	  article	  was	  written	  enrollment	  in	  the	  CSRS	  was	  voluntary	  and	  was	  strongly	  encouraged	  by	  the	  project.	  	   Modification	  of	  opioid	  dispensing	  policy	  by	  hospital	  emergency	  departments	  (ED)	  is	  an	  important	  component	  of	  supply	  reduction	  and	  diversion	  control.	  	  One	  element	  of	  supply	  reduction	  includes	  limiting	  the	  quantity	  of	  medication	  dispensed	  at	  once	  to	  a	  patient,	  thus	  necessitating	  follow	  up	  with	  their	  primary	  care	  provider.	  	  Another	  important	  policy	  modification	  involves	  requiring	  the	  ED	  to	  check	  the	  CSRS	  as	  part	  of	  the	  admissions	  process.	  	  Supply	  reduction	  is	  also	  facilitated	  by	  “take-­‐back”	  events	  held	  by	  public	  safety	  departments	  and	  offering	  medicine	  disposal	  sites	  at	  local	  police	  department	  and	  health	  departments.	  	  	  
Page	  |	  10	  
	   	  Mandatory	  use	  of	  Medicaid	  patient-­‐prescriber	  agreements	  and	  a	  requirement	  for	  patients	  to	  use	  a	  single	  pharmacy	  are	  examples	  of	  policy	  changes	  that	  address	  pain	  patient	  and	  drug	  safety	  concerns.	  	  Medicaid	  patients	  may	  also	  be	  offered	  enrollment	  in	  pain	  support	  groups	  and	  an	  ED	  case	  manager	  for	  beneficiaries	  with	  non-­‐cancer	  chronic	  pain.	  	  Local	  pain	  clinics,	  euphemistically	  termed	  “Pill	  Mills”,	  must	  be	  vetted	  and	  physicians	  must	  facilitate	  referrals	  to	  these	  specialized	  clinics	  and	  ensure	  regular	  follow-­‐ups	  to	  monitor	  for	  addiction.	  	   Addiction	  treatment,	  demand	  reduction,	  and	  harm	  reduction	  constitute	  the	  tertiary	  prevention	  component	  of	  the	  program.	  	  Physician-­‐supervised	  treatment	  with	  Suboxone	  (Buprenorphine),	  either	  in-­‐home	  or	  in	  a	  local	  clinic,	  has	  proven	  to	  be	  safe	  and	  effective.	  	  	  	  For	  victims	  of	  overdose	  the	  opioid	  antagonist	  Naloxone	  (Narcan)	  is	  a	  proven	  antidote	  to	  treat	  for	  acute	  opioid	  overdose	  and	  the	  associated	  respiratory	  depression	  and	  shock.	  	  Physicians	  may	  prescribe	  naloxone	  concurrently	  with	  opioid	  analgesics	  to	  patients	  with	  risk	  factors	  associated	  with	  overdose.	  	  Free	  Naloxone	  “rescue	  kits”,	  consisting	  of	  two	  doses	  of	  the	  medication	  and	  an	  intranasal	  delivery	  device,	  are	  available	  to	  caregivers	  and	  family	  members	  of	  patients	  in	  the	  event	  of	  an	  overdose.	  	  	   Community	  education	  is	  the	  most	  important	  component	  of	  the	  Project	  Lazarus	  intervention	  model.	  	  Education	  efforts	  are	  aimed	  at	  raising	  public	  awareness	  of	  the	  risks	  associated	  with	  opioid	  analgesics	  and	  modifying	  behaviors	  related	  to	  the	  use,	  storage,	  and	  disposal	  of	  these	  medications.	  	  	  School	  based	  education	  campaigns;	  billboard	  messages;	  public	  service	  announcements;	  presentations	  in	  community	  forums;	  and	  radio	  and	  newspaper	  spots	  are	  examples	  of	  community	  level	  education	  efforts.	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Evaluation	  	   Quantitative	  outcome	  evaluation	  data	  were	  obtained	  from	  several	  state	  government	  sources:	  	  (1)	  ED	  visits	  associated	  with	  substance	  abuse	  and	  accidental	  poisonings	  data	  from	  the	  North	  Carolina	  Disease	  Event	  Tracking	  and	  Epidemiological	  Collection	  Tool	  (NC	  DETECT);	  (2)	  outpatient	  dispensed	  controlled	  substances	  from	  the	  Controlled	  Substance	  Reporting	  System;	  (3)	  fatal	  accidental	  poisonings	  from	  the	  North	  Carolina	  Office	  of	  the	  Chief	  Medical	  Examiner;	  and	  (4)	  vital	  statistics	  from	  the	  North	  Carolina	  State	  Center	  for	  Health	  Statistics.	  Unadjusted	  overdose	  mortality	  rate	  dropped	  from	  43	  deaths	  per	  100,000	  population	  in	  2008	  to	  29	  deaths	  per	  100,000	  in	  2010,	  an	  overall	  33%	  reduction.	  	  Mortality	  events	  where	  the	  decedent	  had	  received	  a	  prescription	  for	  an	  opioid	  analgesic	  decreased	  from	  82%	  in	  2008	  to	  10%	  in	  2010,	  a	  reduction	  of	  62%.	  	  Enrollment	  in	  the	  CSRS	  among	  opioid	  prescribing	  physicians	  increased	  to	  70%	  by	  2010;	  the	  comparable	  statewide	  rate	  is	  20%.	   Process	  evaluation	  data	  were	  not	  systematically	  collected;	  however,	  some	  anecdotal	  qualitative	  results	  were	  presented.	  	  A	  community	  coalition	  was	  formed	  to	  coordinate	  overdose	  prevention	  efforts	  and	  community	  boards	  were	  active	  in	  the	  program.	  	  The	  Health	  Department	  medical	  director	  visited	  half	  of	  the	  physicians	  registered	  with	  the	  Drug	  Enforcement	  Administration	  in	  the	  county	  to	  offer	  one-­‐on-­‐one	  education;	  this	  represented	  70%	  of	  office	  practices.	  	  Provider	  “tool	  kits”	  consisting	  of	  pain	  management	  guidelines,	  opioid	  risk	  assessment	  tools,	  “universal	  precautions”	  for	  opioid	  prescribing,	  defensive	  prescription	  writing,	  and	  patient	  educational	  materials	  were	  provided	  to	  prescribing	  physicians.	  The	  one	  hospital	  serving	  the	  county	  modified	  their	  ED	  prescription	  policies	  to	  require	  that	  the	  CSRS	  be	  accessed	  for	  all	  patients	  prescribed	  opioid	  analgesics.	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   An	  important	  strength	  of	  the	  program	  is	  that	  the	  health	  problem	  is	  addressed	  from	  multiple	  levels	  –	  the	  intrapersonal,	  interpersonal,	  organizational,	  community	  and	  public	  policy	  levels.	  	  Influences	  on	  behavior	  are	  known	  to	  interact	  across	  different	  levels,	  and	  multi-­‐level	  interventions	  are	  more	  effective	  in	  creating	  change	  than	  are	  programs	  that	  address	  only	  a	  single	  level	  of	  the	  ecological	  model14.	  	  Community-­‐activation	  is	  recognized	  as	  a	  model	  for	  change	  from	  within	  a	  community,	  and	  is	  key	  for	  generating	  community	  capacity,	  empowerment,	  participation,	  and	  relevance15.	  	   A	  weakness	  of	  the	  program	  is	  the	  difficulty	  of	  establishing	  a	  direct	  causal	  link	  between	  the	  components	  of	  the	  intervention	  and	  the	  outcomes.	  	  Evaluation	  and	  measurement	  of	  potential	  confounders	  is	  necessary	  to	  determine	  if	  the	  reduction	  in	  mortality	  rate	  is	  statistically	  significant.	  	  	  A	  quasi-­‐experimental	  design	  that	  incorporated	  a	  time	  series	  or	  other	  design	  element	  could	  prove	  helpful	  in	  evaluating	  threats	  to	  internal	  validity.	  	  
	  
Provider	  Detailing	  Program	  Provider	  Detailing16	  is	  an	  intervention	  conducted	  in	  Utah	  during	  the	  period	  2008-­‐2009	  in	  response	  to	  an	  increase	  in	  deaths	  related	  to	  prescription	  opioids.	  	  This	  program	  was	  part	  of	  a	  multi-­‐level	  intervention	  on	  the	  part	  of	  the	  State	  of	  Utah	  to	  address	  the	  rising	  death	  rates	  from	  unintentional	  overdose.	  	  Prescriber	  education	  and	  behavior	  change	  is	  the	  basis	  of	  this	  component	  of	  the	  intervention.	  	  The	  State	  of	  Utah	  implemented	  several	  other	  interventions	  concurrently	  with	  the	  provider-­‐detailing	  program:	  (1)	  development	  of	  guidelines	  on	  prescribing	  opioids	  for	  pain;	  (2)	  formation	  of	  county	  coalitions	  for	  addressing	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prescription	  narcotic	  mortality;	  and	  (3)	  multiple	  public	  education	  campaigns.	  	  Interestingly	  these	  other	  simultaneous	  interventions	  were	  not	  coordinated	  under	  a	  unified	  leadership	  structure.	  	   	  The	  objective	  of	  the	  Provider	  Detailing	  program	  was	  to	  introduce	  the	  six	  practices	  of	  safe	  opioid	  prescribing	  to	  primary	  care	  providers.	  	  The	  six	  practices	  are:	  1. Start	  low	  and	  go	  slow	  (refers	  to	  dosing)	  2. Obtain	  sleep	  studies	  for	  all	  patients	  on	  moderate	  or	  high	  doses	  of	  any	  long-­‐acting	  opioid	  3. Obtain	  EKGs	  for	  methadone	  dose	  increases	  up	  to	  and	  above	  50	  mg/day	  (to	  address	  potential	  QT	  prolongation	  4. Avoid	  sleep	  aids	  and	  benzodiazepines	  with	  opioids	  5. Avoid	  long-­‐acting	  opioids	  in	  acute	  pain	  6. Educate	  patients	  and	  their	  families	  about	  risks	  Health	  Insight,	  Utah’s	  Medicare	  Quality	  Improvement	  Organization,	  and	  members	  of	  the	  Prescription	  Pain	  Medication	  Program	  Steering	  Committee	  developed	  the	  six	  practices.	  	  After	  the	  State	  of	  Utah	  had	  developed	  guidelines	  for	  health	  care	  providers	  on	  safe	  prescribing	  the	  program	  was	  expanded	  to	  include	  education	  on	  the	  six	  practices	  and	  the	  guidelines.	  	   The	  target	  population	  for	  the	  intervention	  was	  primary	  care	  physicians	  in	  the	  state	  of	  Utah.	  	  Geographic	  regions	  of	  the	  state	  with	  the	  highest	  rates	  of	  prescription	  opioid	  mortality	  were	  given	  priority.	  	  The	  intervention	  was	  comprised	  of	  a	  1-­‐hour	  presentation	  offered	  in	  physician’s	  practices	  and	  clinics.	  	  The	  presentation	  was	  facilitated	  by	  a	  primary	  care	  physician	  and	  consisted	  of	  a	  description	  of	  the	  health	  problem	  (including	  county	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specific	  data);	  a	  detailed	  discussion	  of	  the	  “six	  practices	  for	  safe	  prescribing”;	  a	  continuous	  quality	  improvement	  dialog;	  and	  discussion	  of	  the	  Utah	  State	  guidelines	  for	  safe	  prescribing.	  	  Pain	  specialists	  were	  included	  as	  facilitators	  when	  possible	  to	  provide	  an	  additional	  level	  of	  expertise	  to	  the	  discussion.	  	  Participants	  received	  a	  copy	  of	  the	  presentation	  slides,	  templates	  for	  chart	  notes,	  treatment	  plan	  examples,	  patient	  education	  materials,	  and	  office	  posters	  describing	  the	  epidemic.	  	  	  During	  the	  presentation	  physicians	  were	  encouraged	  to	  access	  the	  Utah	  controlled	  prescriptions	  database	  to	  review	  their	  patient’s	  prescriptions.	  Evaluation	  At	  the	  conclusion	  of	  the	  presentation	  participants	  were	  surveyed	  to	  evaluate	  their	  baseline	  knowledge	  of	  prescribing	  practices.	  	  Participants	  were	  surveyed	  again	  at	  1	  month	  and	  6	  months	  to	  evaluate	  their	  prescribing	  practices	  and	  the	  degree	  to	  which	  they	  had	  adopted	  the	  six	  practices	  and	  guidelines.	  	  Continuing	  education	  credits	  were	  used	  to	  incentivize	  participants	  to	  complete	  the	  survey	  questionnaires.	  	  	  	   Results	  for	  the	  process	  evaluation	  were	  mixed.	  	  A	  total	  of	  46	  presentations	  were	  given	  during	  2008	  with	  581	  physicians	  in	  attendance.	  	  Follow	  up	  surveys	  were	  received	  from	  366	  participants	  immediately	  following	  the	  presentations;	  surveys	  at	  one	  month	  and	  six	  months	  yielded	  82	  and	  29	  responses	  respectively.	  	  A	  large	  majority	  of	  participants	  (85%)	  reported	  feeling	  confident	  that	  they	  could	  describe	  and	  implement	  safe	  prescribing	  practices	  and	  guidelines	  for	  opioids.	  	  	  	  A	  majority	  (60%	  -­‐	  80%)	  reported	  no	  longer	  prescribing	  long-­‐acting	  opioids	  for	  acute	  pain,	  or	  in	  combination	  with	  benzodiazepine	  sedatives.	  	  A	  smaller	  majority	  (>50%)	  reported	  using	  the	  Utah	  control	  substances	  database	  when	  administering	  patient	  care,	  lowered	  initial	  dosages,	  and	  slowed	  dosage	  increases.	  	  A	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minority	  of	  physicians	  (30%	  -­‐	  50%)	  reported	  increasing	  referrals	  to	  sleep	  studies	  for	  patients,	  using	  EKGs	  for	  methadone	  patients,	  using	  patient	  educational	  tools,	  or	  using	  Utah’s	  prescribing	  guidelines	  in	  their	  practices.	  	   The	  impact	  evaluation	  showed	  a	  14%	  reduction	  in	  unintentional	  overdose	  mortality	  in	  2008	  versus	  2007	  (301	  deaths	  vs.	  259).	  	  One	  year	  following	  the	  intervention	  (2009)	  deaths	  rose	  from	  259	  to	  265.	  	  	  	   A	  strength	  of	  the	  program	  was	  the	  high	  response	  rate	  for	  prescriber	  compliance	  with	  some	  elements	  of	  the	  “six	  practices”,	  particularly	  the	  reduction	  in	  prescription	  of	  opioids	  for	  acute	  pain,	  or	  in	  combination	  with	  sedatives.	  	  The	  program	  also	  showed	  a	  majority	  of	  participants	  utilizing	  the	  controlled	  substances	  database.	  	  The	  use	  of	  primary	  care	  physicians	  to	  facilitate	  the	  presentations	  was	  a	  good	  strategy	  to	  improve	  the	  credibility	  of	  the	  message	  to	  the	  target	  audience.	  	  	  	   A	  weakness	  of	  the	  program	  was	  the	  lack	  of	  unified	  leadership	  and	  coordination	  with	  other	  ongoing	  interventions.	  	  The	  study	  also	  suffered	  from	  a	  very	  low	  response	  rate	  for	  surveys	  taken	  at	  1	  month	  and	  6	  months	  post	  intervention.	  	  These	  factors,	  in	  combination	  with	  multiple	  confounders	  (i.e.,	  concurrent	  interventions)	  and	  lack	  of	  experimental	  controls	  or	  time	  series	  data,	  limit	  the	  study’s	  usefulness	  in	  evaluating	  causality	  or	  external	  validity.	  
	  
Overdose	  Prevention	  and	  Reversal	  Program	  Program	  The	  Overdose	  Prevention	  and	  Reversal	  Program17was	  initiated	  as	  a	  pilot	  program	  in	  New	  York	  City	  (NYC)	  to	  address	  epidemic	  levels	  of	  overdose	  deaths	  among	  injection	  drug	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users.	  	  During	  2003	  between	  800	  to	  900	  persons	  died	  from	  drug-­‐induced	  overdose	  in	  NYC	  200318;	  the	  overdose	  death	  rate	  exceeded	  the	  homicide	  rate	  during	  that	  period.	  	  This	  prevention	  initiative	  describes	  a	  program	  implemented	  in	  2004	  to	  prescribe	  urban	  injection	  drug	  users	  with	  Naloxone,	  an	  opioid	  antagonist,	  to	  reverse	  the	  effects	  of	  opioid	  overdose.	  	  	  	  Volunteers	  for	  the	  program	  were	  recruited	  from	  clients	  of	  the	  Lower	  East	  Side	  Harm	  Reduction	  Center	  (LESHRC)	  needle	  exchange	  program.	  	  Individuals	  from	  the	  LESHRC	  were	  thought	  to	  have	  routine	  contact	  with	  other	  injection	  drug	  users	  and	  therefore	  be	  in	  a	  position	  to	  intervene	  in	  the	  case	  of	  overdoses.	  	  The	  program	  consisted	  of	  three	  major	  components:	  	  (1)	  overdose	  risk	  and	  response	  training;	  (2)	  physician	  approval	  of	  participants	  and	  prescribing	  of	  Naloxone	  syringes;	  and	  (3)	  evaluation	  and	  follow	  up	  after	  3	  months.	  	  In	  the	  first	  phase	  of	  the	  program	  participants	  underwent	  a	  intensive	  one-­‐hour	  training	  session	  to	  introduce	  the	  skills	  necessary	  to	  assess	  overdose	  victims:	  	  (1)	  activate	  Emergency	  Medical	  Services,	  	  (2)	  position	  the	  victim	  in	  the	  rescue	  breathing	  position,	  and	  (3)	  administer	  up	  to	  2	  doses	  of	  0.4	  mg	  Naloxone	  intramuscularly.	  	  Clinic	  medical	  staff	  conducted	  training	  in	  small	  groups	  or	  one-­‐on-­‐one.	  Following	  the	  training	  session	  participants	  met	  individually	  with	  a	  clinic	  physician,	  who	  would	  review	  the	  training	  and	  assess	  the	  suitability	  of	  the	  participant	  for	  the	  program.	  	  If	  the	  participant	  was	  deemed	  willing	  and	  capable	  of	  performing	  the	  necessary	  actions	  the	  physician	  would	  issue	  a	  prescription	  for	  two	  1	  cc	  syringes	  pre-­‐loaded	  with	  0.4	  mg	  naloxone	  for	  intramuscular	  injection.	  	  LESHRC	  staff	  would	  obtain	  the	  medication	  and	  subsequently	  provide	  the	  participant	  with	  the	  medication.	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Evaluation	  Clinic	  staff	  administered	  a	  baseline	  assessment	  to	  each	  participant	  to	  collect	  program	  information	  including	  demographics,	  drug	  use	  history,	  overdose	  history,	  overdoses	  witnessed,	  and	  behaviors	  during	  witnessed	  overdoses.	  	  After	  a	  3-­‐month	  interval,	  or	  during	  the	  interim	  if	  the	  participant	  required	  a	  Naloxone	  refill,	  the	  participant	  was	  reassessed	  using	  a	  modified	  version	  of	  the	  baseline	  assessment.	  	  Participants	  were	  asked	  about	  their	  experiences	  since	  the	  baseline	  assessment,	  such	  as	  how	  many	  overdoses	  they	  witnessed,	  details	  about	  the	  overdose	  incidents,	  and	  what	  actions,	  if	  any,	  they	  personally	  undertook	  during	  the	  incidents.	  	  Participants	  were	  also	  assessed	  on	  their	  personal	  comfort	  level	  with	  administering	  Naloxone.	  Twenty-­‐five	  participants	  were	  recruited	  into	  the	  program.	  	  A	  majority	  of	  participants	  were	  male	  (92%),	  white	  (64%),	  had	  personally	  experienced	  an	  overdose	  (68%),	  and	  had	  witnessed	  another	  person	  overdose	  (83%).	  	  During	  the	  6	  months	  prior	  to	  volunteering	  for	  the	  program	  most	  participants	  had	  injected	  heroin	  (80%),	  had	  injected	  cocaine	  or	  crack	  (48%),	  and	  had	  been	  in	  a	  methadone	  maintenance	  program	  (68%).	  	  Most	  also	  reported	  alcohol	  use	  (50%)	  and	  sniffing	  or	  snorting	  cocaine	  and/or	  crack	  (40%	  and	  29%	  respectively).	  	  The	  sample	  size	  was	  insufficient	  to	  provide	  statistically	  significant	  results;	  however,	  the	  trends	  in	  the	  data	  showed	  measureable	  improvement	  in	  key	  process	  metrics	  at	  3	  months	  after	  baseline.	  	  Twenty-­‐two	  participants	  (88%)	  were	  successfully	  followed	  up	  after	  3-­‐months.	  	  Activation	  of	  EMS	  improved	  from	  58%	  at	  baseline	  to	  82%	  at	  follow	  up.	  	  Assessment	  behavior	  (e.g.,	  calling	  the	  patient’s	  name	  to	  try	  to	  wake	  them	  up)	  improved	  from	  53%	  at	  baseline	  to	  73%;	  moving	  the	  patient	  to	  the	  recovery	  position	  improved	  from	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5.3%	  to	  18%;	  and	  initiation	  of	  CPR	  improved	  from	  5.3%	  to	  27%.	  	  Negative	  behaviors	  such	  as	  injecting	  the	  patient	  with	  cocaine,	  water	  or	  salt	  dropped	  from	  16%	  to	  0%,	  and	  “doing	  nothing”	  decreased	  from	  21%	  to	  0%.	  Of	  the	  22	  participants	  followed	  up	  at	  3	  months,	  11	  reported	  witnessing	  one	  or	  more	  overdoses.	  	  A	  total	  of	  17	  overdoses	  were	  observed;	  of	  those	  incidents	  naloxone	  was	  administered	  in	  10	  instances.	  	  All	  patients	  to	  whom	  naloxone	  was	  administered	  survived.	  	  Among	  those	  instances	  where	  naloxone	  was	  not	  administered,	  five	  survived,	  one	  died,	  and	  one	  outcome	  was	  unknown.	  The	  use	  of	  volunteer	  participants	  who	  were	  existing	  injection	  drug	  users,	  and	  therefore	  very	  familiar	  with	  the	  community,	  was	  a	  strength	  of	  the	  program.	  	  These	  participants’	  personal	  history	  of	  illicit	  drug	  use	  and	  their	  ability	  to	  come	  in	  frequent	  contact	  with	  persons	  at	  risk	  placed	  them	  in	  an	  ideal	  position	  to	  provide	  help	  when	  needed.	  	  The	  88%	  response	  rate	  after	  3-­‐month	  follow	  up	  indicates	  a	  high	  level	  of	  personal	  motivation	  and	  “buy-­‐in”	  to	  the	  program,	  and	  to	  the	  welfare	  of	  the	  victims	  of	  overdose.	  	  In	  some	  sense	  this	  represents	  a	  sort	  of	  community	  activation,	  in	  that	  members	  of	  this	  community	  are	  working	  to	  reduce	  harm	  among	  their	  own	  members.	  	  A	  weakness	  of	  the	  program	  is	  the	  lack	  of	  community	  involvement	  in	  the	  development	  of	  the	  intervention.	  	  Other	  weaknesses	  cited	  by	  the	  program	  include	  the	  use	  of	  early	  volunteers	  who	  may	  be	  more	  motivated	  than	  more	  representative	  users	  (i.e.,	  selection	  bias),	  small	  sample	  size,	  low	  statistical	  power,	  and	  the	  use	  of	  self-­‐reported	  data	  (reporting	  bias).	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Risk	  Evaluation	  and	  Mitigation	  Strategies	  (REMS)	  Program	  Prescription	  opioid	  analgesics	  are	  an	  indispensable	  option	  for	  patients	  with	  long-­‐term	  chronic	  pain,	  particularly	  cancer	  patients	  suffering	  from	  intractable	  pain.	  	  	  However,	  the	  upsurge	  in	  overdose	  deaths	  coinciding	  with	  the	  10-­‐fold	  increase	  in	  the	  volume	  of	  opioid	  analgesics	  prescribed	  over	  the	  previous	  20	  years	  raised	  safety	  concerns	  with	  the	  US	  Food	  and	  Drug	  Administration19.	  	  Of	  particular	  concern	  to	  the	  agency	  are	  extended-­‐release	  (ER)/long-­‐acting	  (LA)	  opioids	  commonly	  used	  for	  severe	  chronic	  pain	  requiring	  around-­‐the-­‐clock	  analgesia.	  	  In	  response	  to	  these	  safety	  concerns	  the	  US	  FDA	  developed	  a	  comprehensive	  risk	  management	  program,	  or	  Risk	  Evaluation	  and	  Mitigation	  Strategies	  (REMS)	  20,	  for	  medications	  with	  known	  or	  potential	  risks.	  	  	  The	  REMS	  provide	  guidance	  to	  prescribers	  to	  improve	  safe	  and	  appropriate	  prescribing	  by	  educating	  physicians	  and	  patients	  of	  the	  unique	  risks	  associated	  with	  the	  medication.	  	  	   Under	  the	  authority	  of	  the	  Food	  and	  Drug	  Administration	  Amendments	  Act	  of	  2007	  designated	  medications	  are	  required	  to	  have	  a	  REMS	  to	  ensure	  the	  benefits	  of	  the	  medication	  continue	  to	  outweigh	  the	  risks21.	  	  The	  REMS	  consists	  of	  a	  maximum	  of	  five	  components:	  	  Patient	  Medication	  Guide;	  Communications	  Plan;	  Elements	  to	  Assure	  Safe	  Use	  (ETASU);	  Implementation	  System;	  and	  Assessments.	  	  The	  components	  chosen	  for	  the	  REMS	  depend	  on	  the	  characteristics	  and	  risks	  associated	  with	  the	  particular	  medication.	  	  In	  2009	  the	  US	  FDA	  recommended	  three	  components	  for	  a	  class-­‐wide	  REMS	  covering	  all	  ER/LA	  opioids:	  	  (1)	  Patient	  Medication	  Guide;	  (2)	  Elements	  to	  Assure	  Safe	  Use;	  and	  (3)	  Timetable	  for	  Submission	  of	  Assessments.	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   The	  Patient	  Medication	  Guide	  is	  provided	  to	  all	  patients	  prescribed	  ER/LA	  opioid	  analgesics	  and	  offers	  general	  information	  on	  the	  class	  of	  medication	  and	  product	  specific	  guidance	  for	  use.	  	  For	  example,	  the	  Guide	  offers	  information	  on	  proper	  dosing,	  safe	  storage,	  disposal	  recommendations,	  tampering	  risks,	  and	  risks	  associated	  with	  concurrent	  use	  of	  alcohol	  and	  other	  depressants.	  	  	  	   The	  second	  element	  of	  the	  ER/LA	  opioids	  REMS	  is	  a	  blueprint	  for	  a	  comprehensive	  “Elements	  to	  Assure	  Safe	  Use”	  educational	  program	  for	  prescribers	  of	  opioids.	  	  The	  elements	  of	  the	  education	  program	  include	  the	  following	  topics:	  
• Patient	  selection	  for	  opioid	  therapy	  
• Initiation	  of	  opioid	  therapy,	  dose	  titration,	  and	  discontinuation	  of	  use	  
• Patient	  management	  
• General	  ER/LA	  class-­‐wide	  opioid	  information	  
• Ensuring	  opioid	  tolerance	  for	  fentanyl	  hydromorphone	  ER	  and	  for	  select	  doses	  of	  other	  ER	  opioids	  
• Product	  specific	  information	  
• Counseling	  for	  patients	  and	  caregivers.	  The	  element	  of	  the	  ETASU	  are	  expected	  to	  be	  covered	  in	  a	  2-­‐3	  hour	  continuing	  medical	  education	  course	  offered	  by	  an	  accredited	  provider.	  	  Educational	  materials	  to	  assist	  physicians	  during	  patient	  counseling	  sessions	  are	  incorporated	  included	  as	  part	  of	  the	  training.	  	  	  Evaluation	  	   The	  third	  component	  of	  the	  REMS	  is	  a	  Timetable	  for	  Submission	  of	  Assessments	  by	  the	  drug	  manufacturer,	  to	  determine	  if	  the	  benefits	  of	  the	  drug	  continue	  to	  outweigh	  the	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risks.	  	  Assessments	  are	  in	  essence	  process	  and	  outcome	  evaluation	  studies,	  where	  the	  program	  components	  and	  the	  health	  outcomes	  are	  systematically	  examined.	  	  Assessments	  are	  normally	  required	  at	  intervals	  of	  18	  months,	  3	  years,	  and	  7	  years	  after	  approval	  of	  the	  REMS.	  	  More	  frequent	  assessment	  may	  be	  required	  depending	  on	  the	  size	  of	  the	  population	  using	  the	  drug,	  the	  seriousness	  of	  the	  risks,	  and	  knowledge	  of	  the	  effectiveness	  of	  the	  REMS	  in	  mitigating	  the	  risks	  associated	  with	  the	  medication.	  	  After	  the	  3	  year	  assessment	  the	  FDA	  may	  accept	  elimination	  of	  further	  assessments	  if	  the	  risks	  of	  the	  drug	  have	  been	  well	  identified	  and	  effectively	  managed.	  	  	   The	  REMS	  program	  is	  an	  example	  of	  a	  top	  down	  policy	  intervention	  implemented	  in	  response	  to	  potential	  risks	  associated	  with	  prescription	  drugs.	  	  A	  strength	  of	  this	  program	  is	  the	  flexibility	  that	  enables	  the	  program	  to	  be	  tailored	  to	  the	  characteristics	  and	  risks	  associated	  with	  each	  drug	  or	  drug	  class.	  	  The	  educational	  requirements	  for	  physicians	  are	  comprehensive	  and	  require	  a	  skills-­‐based	  exam	  to	  ensure	  that	  the	  training	  material	  has	  been	  understood.	  	  Periodic	  assessments	  will	  help	  ensure	  that	  the	  “intervention”	  is	  working	  to	  mitigate	  potential	  risks	  and	  protect	  patient	  wellness.	  	   Patients	  in	  need	  of	  long-­‐term,	  around	  the	  clock	  analgesia	  may	  experience	  restricted	  access	  to	  ER/LA	  opioids.	  	  This	  is	  a	  serious	  concern,	  which	  has	  been	  raised	  to	  the	  US	  FDA.	  	  The	  FDA	  has	  explicitly	  stated	  that	  the	  intent	  of	  the	  program	  is	  not	  to	  restrict	  access	  to	  medications	  that	  are	  necessary	  for	  patient	  treatment,	  rather	  to	  desire	  is	  to	  ensure	  the	  risk/benefits	  balance	  is	  appropriate.	  	  However,	  as	  with	  any	  policy,	  close	  vigilance	  and	  continued	  assessment	  of	  the	  program	  as	  advisable.	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Overdose	  Prevention	  and	  Response	  Training	  Program	  for	  Injection	  Drug	  Users	  Program	  The	  Overdose	  Prevention	  and	  Response	  Training	  Program22	  addresses	  the	  problem	  of	  opioid	  overdose	  among	  injection	  drug	  users	  (IDUs)	  in	  the	  “Skid	  Row”	  area	  of	  Los	  Angeles,	  California.	  	  Drug	  overdose	  was	  identified	  as	  the	  fourth	  leading	  cause	  of	  death	  in	  this	  geographic	  region.	  	  The	  area	  is	  characterized	  by	  a	  high	  crime	  rate,	  a	  high	  concentration	  of	  homelessness,	  and	  a	  30%	  rate	  of	  illicit	  drug	  use.	  	  Like	  the	  Overdose	  Prevention	  and	  Reversal	  Program	  discussed	  earlier,	  this	  intervention	  relies	  on	  developing	  the	  skills	  of	  IDUs	  to	  prevent,	  recognize,	  and	  respond	  to	  opioid	  overdose	  events	  in	  the	  community.	  	  	  Participants	  who	  were	  recruited	  for	  the	  intervention	  learned	  critical	  intervention	  skills	  including	  understanding	  the	  mechanism	  of	  overdose;	  strategies	  for	  prevention;	  recognizing	  symptoms;	  and	  recommended	  response	  techniques.	  	  	  	   The	  Homeless	  Health	  Care	  Los	  Angeles	  Center	  for	  Harm	  Reduction	  (HHCLA-­‐HRC),	  a	  community-­‐based	  non-­‐profit	  organization,	  developed	  and	  implemented	  the	  intervention.	  	  Clients	  of	  the	  HHCLA-­‐HRC	  were	  recruited	  via	  various	  outreach	  methods	  and	  provided	  with	  a	  1-­‐hour	  hands-­‐on	  demonstration	  and	  practice	  session	  based	  on	  a	  curriculum	  developed	  by	  the	  Chicago	  Recovery	  Alliance	  (http://www.anypositivechange.org/menu.html).	  	  	  	  Calling	  for	  help,	  checking	  the	  airway,	  rescue	  breathing,	  evaluation,	  intramuscular	  administration	  of	  Naloxone,	  and	  support	  were	  the	  basic	  skills	  learned	  during	  the	  session.	  	  Training	  was	  conducted	  in	  small	  groups	  (two	  to	  six	  individuals)	  and	  was	  facilitated	  by	  one	  or	  two	  trainers.	  	  Discussion	  was	  encouraged	  during	  the	  session	  and	  participants	  were	  required	  to	  demonstrate	  their	  newfound	  skills	  to	  the	  satisfaction	  of	  the	  training	  staff.	  	  Upon	  successful	  completion	  of	  the	  training	  participants	  met	  with	  a	  staff	  physician	  who	  provided	  two	  single	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dose	  syringes	  pre-­‐filled	  with	  4mg	  Naloxone.	  	  Participants	  also	  received	  a	  “kit”	  containing	  latex	  gloves,	  alcohol	  swabs,	  a	  rescue	  breathing	  mask,	  and	  a	  small	  card	  describing	  the	  response	  technique.	  	  	  Evaluation	  	   Study	  outcomes	  were	  evaluated	  using	  four	  broad	  metrics:	  	  Did	  (1)	  participants	  increase	  their	  knowledge	  of	  Naloxone	  and	  overdose	  risks/symptoms;	  (2)	  improve	  their	  attitudes	  to	  overdose	  response	  and	  summoning	  emergency	  services;	  (3)	  increase	  the	  frequency	  with	  which	  they	  engaged	  in	  recommended	  response	  techniques;	  and	  (4)	  decrease	  the	  frequency	  with	  which	  they	  engaged	  in	  non-­‐recommended	  response	  techniques.	  	  Data	  collection	  was	  conducted	  at	  baseline	  and	  at	  3	  months	  following	  the	  training	  session.	  	  Trained	  interviewers	  collected	  demographics,	  housing	  status,	  drug	  use	  behavior,	  witnessed	  overdoses,	  techniques	  used	  to	  respond,	  and	  outcomes	  (e.g.	  survived,	  not	  survived,	  unknown).	  	  Qualitative	  data	  measures	  regarding	  attitudes	  towards	  responding	  were	  assessed	  using	  a	  five-­‐point	  Likert	  scale	  to	  facilitate	  quantitative	  analysis.	  	  	  	   Ninety-­‐three	  IDUs	  were	  recruited	  for	  training	  between	  September	  2006	  and	  January	  2008.	  	  Of	  this	  group,	  sixty-­‐six	  agreed	  to	  enroll	  in	  the	  study	  and	  completed	  the	  initial	  training.	  	  The	  majority	  were	  male	  (79%),	  average	  age	  46,	  white	  (42%),	  African	  American	  (29%),	  Latino	  (18%),	  homeless	  (44%),	  and	  heroin	  users	  (97%).	  	  Nearly	  half	  (49%)	  of	  the	  initial	  group	  of	  sixty-­‐six	  enrolled	  in	  the	  study	  reported	  witnessing	  at	  least	  one	  overdose	  event,	  and	  10	  (15%)	  reported	  experiencing	  an	  overdose	  themselves.	  	  After	  accounting	  for	  loss	  to	  follow	  up	  (n=19)	  and	  incarceration	  (n=9)	  the	  final	  sample	  size	  consisted	  of	  forty-­‐seven	  participants	  who	  had	  completed	  the	  3-­‐month	  follow	  up	  assessment.	  	  Demographic	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characteristics	  of	  the	  forty-­‐seven	  remaining	  participants	  closely	  mirrored	  the	  initial	  retained	  group.	  	  	  	   After	  the	  3-­‐month	  follow	  up	  period	  the	  study	  found	  a	  statistically	  significant	  increase	  in	  scores	  for	  overall	  baseline	  knowledge;	  scores	  increased	  from	  77%	  to	  92%	  (P<0.0001).	  	  No	  changes	  in	  attitudes	  were	  observed	  about	  overdose	  response,	  including	  the	  likelihood	  of	  administering	  Naloxone	  or	  contacting	  emergency	  services.	  	  	  A	  majority	  of	  participants	  (53%)	  reported	  that	  their	  drug	  use	  had	  decreased,	  and	  an	  increased	  proportion	  enrolled	  in	  drug	  treatment	  (23%	  to	  36%).	  	  During	  the	  follow	  up	  period	  twenty-­‐two	  participants	  responded	  to	  a	  total	  of	  35	  overdoses,	  most	  of	  whom	  were	  strangers	  (40%)	  or	  associates/acquaintances	  (31%).	  	  A	  statistically	  significant	  improvement	  in	  behavior	  in	  response	  to	  witnessed	  overdoses	  was	  shown;	  the	  mean	  number	  of	  recommended	  response	  techniques	  increased	  (P=0.01),	  while	  the	  number	  of	  non	  recommended	  responses	  decreased,	  although	  not	  by	  a	  statistically	  significant	  amount.	  	  The	  proportion	  of	  victims	  who	  died	  at	  the	  scene	  remained	  unchanged	  during	  the	  study	  period	  (9%	  at	  baseline	  vs.	  11%	  after	  3	  month	  follow	  up).	  	   A	  strength	  of	  the	  program	  was	  the	  use	  of	  a	  community-­‐based	  organization	  to	  implement	  the	  intervention,	  as	  community	  engagement	  is	  known	  to	  improve	  community	  capacity	  and	  “buy-­‐in”.	  	  Enlisting	  the	  assistance	  of	  trained	  interviewers	  to	  conduct	  the	  surveys	  enhanced	  validity	  by	  reducing	  the	  threat	  due	  to	  instrument	  bias.	  	  Given	  the	  high	  rate	  of	  homelessness,	  drug	  use,	  and	  poverty	  faced	  by	  the	  program	  participants	  the	  follow	  up	  rate	  of	  71%	  was	  very	  impressive.	  	  The	  high	  follow	  up	  rate	  contributed	  to	  the	  internal	  validity	  of	  the	  study.	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   Weaknesses	  of	  the	  program	  included	  selection	  bias;	  selection	  of	  participants	  was	  not	  random	  and	  therefore	  the	  may	  not	  be	  representative	  of	  the	  IDU	  population.	  	  Other	  threats	  to	  validity	  include	  maturation,	  testing	  effects,	  and	  recall	  bias.	  
Analysis	  All	  of	  the	  programs	  evaluated	  shared	  a	  common	  goal	  of	  reducing	  the	  incidence	  of	  overdose	  mortality	  associated	  with	  opioids.	  	  The	  programs	  differed	  markedly	  in	  the	  target	  populations	  they	  served	  and	  in	  the	  level	  of	  community	  involvement	  required	  to	  implement	  the	  interventions.	  	  In	  the	  case	  of	  the	  Project	  Lazarus	  program	  the	  target	  population	  was	  not	  explicitly	  stated,	  but	  the	  primary	  thrust	  of	  the	  program	  appeared	  to	  target	  overdose	  deaths	  from	  legitimate	  users	  of	  prescription	  opioid	  analgesics.	  	  A	  secondary	  goal	  of	  the	  program	  was	  to	  reduce	  diversion	  by	  encouraging	  better	  storage	  and	  disposal	  practices,	  thus	  reducing	  overdose	  deaths	  by	  illicit	  users.	  	  The	  Provider-­‐Detailing	  physician	  education	  intervention	  in	  Utah	  shared	  a	  similar	  target	  population	  to	  Project	  Lazarus.	  	  However,	  this	  was	  a	  much	  more	  limited	  intervention	  in	  that	  it	  did	  not	  include	  other	  elements	  of	  the	  Lazarus	  intervention	  such	  as	  community-­‐building,	  diversion	  control,	  demand	  reduction,	  harm	  reduction	  or	  community	  education.	  	  In	  fairness,	  some	  of	  the	  other	  elements	  of	  Lazarus	  were	  included	  separately	  in	  the	  Utah	  intervention,	  although	  the	  study	  summarized	  only	  the	  physician	  education	  component.	  	  Not	  surprisingly	  the	  efficacy	  of	  the	  Utah	  intervention	  study	  suffered	  from	  confounders	  that	  limited	  the	  ability	  of	  the	  study	  authors	  to	  attribute	  the	  reduction	  in	  opioid	  mortality	  to	  the	  intervention.	  Two	  of	  the	  evaluated	  interventions	  targeted	  a	  narrow	  population	  group:	  injection	  drug	  users	  in	  a	  large	  urban	  metropolis.	  	  Homelessness,	  a	  high	  proportion	  of	  racial	  minorities,	  and	  extensive	  use	  of	  illicit	  drugs	  characterized	  the	  demographics	  of	  this	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population	  group.	  	  Intervention	  strategies	  employed	  by	  both	  of	  the	  programs	  were	  virtually	  identical;	  volunteer	  participants,	  consisting	  mostly	  of	  existing	  IDUs,	  were	  provided	  one	  hour	  of	  intensive	  training	  and	  then	  given	  Naloxone	  overdose	  antidote	  to	  administer	  to	  victims	  as	  needed.	  	  The	  foundational	  assumption	  of	  the	  intervention	  was	  that	  members	  of	  this	  narrow	  population	  were	  in	  the	  best	  position	  to	  identify	  and	  assist	  overdose	  victims,	  many	  of	  whom	  were	  reluctant	  to	  assist	  or	  call	  for	  emergency	  services	  for	  fear	  of	  being	  arrested	  by	  police.	  	  Community	  based	  organizations	  developed	  and	  managed	  both	  of	  the	  interventions	  and	  they	  seemed	  to	  have	  success	  recruiting	  volunteers	  for	  their	  respective	  programs.	  	  Interestingly,	  the	  outcome	  goal	  of	  the	  New	  York	  intervention	  was	  stated	  as	  reducing	  overdose	  deaths,	  while	  the	  Los	  Angeles	  program’s	  goals	  were	  to	  improve	  the	  knowledge	  and	  skills	  of	  participants	  to	  intervene	  and	  provide	  assistance	  to	  victims.	  	  This	  appeared	  to	  be	  an	  acknowledgement	  by	  the	  Los	  Angeles	  organization	  that	  community	  empowerment	  was	  the	  principle	  goal.	  	  	   The	  Risk	  Evaluation	  and	  Mitigation	  Strategies	  (REMS)	  intervention	  by	  the	  US	  Food	  and	  Drug	  Administration	  differs	  from	  the	  other	  evaluated	  interventions	  in	  that	  it	  is	  a	  top-­‐down	  policy	  program,	  as	  opposed	  to	  a	  local	  community	  level	  program.	  	  Some	  similarities	  exist	  with	  the	  Lazarus	  and	  Provider-­‐Detailing	  programs;	  physician	  education	  and	  assessments	  are	  integral	  components	  of	  each	  of	  these	  interventions.	  	  US	  FDA	  provides	  guidance	  to	  drug	  manufacturers	  in	  deciding	  which	  of	  the	  five	  REMS	  components	  are	  necessary,	  and	  the	  goals	  and	  content	  of	  the	  final	  REMS	  are	  left	  to	  the	  manufacturer	  depending	  on	  the	  drug	  to	  which	  it	  applies.	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Conclusion	  The	  literature	  review	  shows	  evidence	  to	  support	  a	  community-­‐based,	  multi-­‐level	  intervention	  program	  to	  address	  the	  epidemic	  of	  prescription	  and	  illicit	  opioid	  overdose	  mortality.	  	  Multi-­‐level	  interventions	  such	  as	  Project	  Lazarus	  and	  Provider-­‐Detailing	  have	  been	  effective	  in	  reducing	  the	  opioid	  overdose	  mortality	  rate	  among	  users	  of	  prescription	  opioid	  analgesics.	  	  Single	  level	  interventions,	  such	  as	  the	  Naloxone	  programs	  implemented	  in	  New	  York	  City	  and	  Los	  Angeles,	  have	  demonstrated	  the	  effectiveness	  of	  harm	  reduction	  programs	  among	  a	  racially	  diverse	  population	  of	  injection	  drug	  users.	  	  	   Building	  a	  coalition	  that	  includes	  stakeholders	  from	  various	  segments	  of	  the	  community	  is	  an	  important	  element	  of	  the	  program.	  	  Coalition	  partners	  are	  needed	  from	  local	  health	  departments,	  physicians	  groups,	  hospital	  organizations,	  emergency	  services,	  and	  faith-­‐based	  groups.	  	  	  The	  organizations	  are	  critical	  to	  a	  successful	  program	  because	  the	  opioid	  overdose	  epidemic	  reaches	  into	  many	  population	  groups,	  not	  simply	  licit	  users	  of	  prescription	  medications.	  	  Diversion	  of	  medications	  exposes	  these	  potentially	  dangerous	  drugs	  to	  a	  much	  larger	  population	  than	  prescription	  users.	  	  A	  broad	  coalition	  ensures	  that	  the	  voices	  of	  the	  community	  are	  brought	  together	  to	  bring	  a	  wide	  range	  of	  expertise	  to	  bear	  on	  the	  problem.	  	   A	  well-­‐defined	  process	  and	  outcome	  evaluation	  program	  is	  crucial	  to	  ensure	  that	  stakeholders	  and	  program	  staff	  are	  well	  apprised	  of	  progress	  and	  to	  assist	  with	  development	  of	  grant	  funding.	  	  The	  interventions	  summarized	  in	  the	  literature	  review	  did	  not	  have	  a	  consistent	  set	  of	  evaluation	  metrics,	  and	  therefore	  measuring	  success	  or	  failure	  was	  problematic.	  	  Program	  management	  will	  benefit	  from	  detailed	  process	  evaluation	  criteria	  to	  keep	  the	  program	  “on-­‐track”.	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Program	  Plan	  
Overview	  I	  propose	  a	  multi-­‐part	  program	  to	  reduce	  the	  incidence	  of	  opioid	  overdose	  morbidity	  and	  mortality	  by	  targeting	  the	  principle	  causes	  of	  overdose	  and	  incorporating	  primary,	  secondary,	  and	  tertiary	  prevention	  efforts	  at	  the	  community	  level.	  	  	  The	  program	  incorporates	  five	  major	  components:	  	  (1)	  community-­‐action	  and	  coalition	  building;	  (2)	  education	  and	  training	  of	  prescribers	  of	  opioid	  analgesics	  and	  their	  patients	  (primary	  prevention);	  	  (3)	  supply	  reduction	  and	  diversion	  control;	  (4)	  harm	  reduction	  and	  treatment;	  and	  (5)	  evaluation.	  	  	  I	  will	  provide	  a	  detailed	  description	  of	  each	  of	  the	  five	  components	  and	  offer	  specific	  goals	  and	  objectives	  for	  each	  component.	  	  Coalition	  building	  is	  the	  first	  and	  most	  important	  step	  to	  initiate	  the	  program.	  	  Success	  of	  the	  program	  is	  contingent	  upon	  the	  active	  participation	  and	  cooperation	  of	  the	  numerous	  organizations	  involved	  in	  the	  intervention.	  	  Chief	  among	  those	  is	  the	  local	  Health	  Department;	  the	  Health	  Department	  Director	  must	  provide	  the	  impetus	  and	  leadership	  to	  build	  the	  community	  coalition	  and	  offer	  the	  public	  health	  expertise	  necessary	  to	  administer	  a	  major	  intervention	  program.	  	  Leaders	  from	  local	  physicians	  groups,	  hospital	  emergency	  departments,	  pharmacies,	  state	  agencies,	  and	  clinics	  must	  be	  recruited	  for	  their	  clinical	  knowledge	  and	  ability	  to	  “spread	  the	  word”	  among	  the	  physician	  community.	  	  	  Community	  health	  organizations,	  such	  as	  Community	  Care	  North	  Carolina	  and	  North	  Carolina	  Foundation,	  must	  be	  brought	  into	  the	  coalition,	  as	  well	  as	  substance	  abuse	  services	  providers	  (e.g.,	  North	  Carolina	  Coalition	  Initiative)	  and	  mental	  health	  providers.	  	  Church	  groups,	  service	  organizations,	  and	  other	  groups	  that	  serve	  the	  homeless	  and	  other	  vulnerable	  populations	  are	  important	  to	  include	  in	  the	  coalition.	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Education	  for	  providers	  and	  patients	  is	  the	  most	  important	  element	  of	  primary	  prevention.	  	  Medical	  schools	  have	  historically	  placed	  limited	  emphasis	  on	  the	  topic	  of	  pain	  treatment	  or	  addiction	  prevention23.	  	  	  	  Awareness	  of	  the	  issue,	  followed	  by	  development	  of	  guidelines	  and	  training,	  is	  the	  first	  step	  in	  addressing	  the	  problem.	  	  	  The	  provider	  education	  component	  of	  this	  program	  includes	  training	  in	  the	  physiology	  of	  opioid	  addiction,	  guidelines	  for	  responsible	  opioid	  prescribing11,	  treatment	  plans,	  and	  patient	  education.	  	  A	  toolkit	  published	  by	  the	  Community	  Care	  of	  North	  Carolina	  (CCNC)	  Chronic	  Pain	  Initiative	  is	  the	  basis	  of	  the	  training	  program	  and	  provides	  detailed	  guidance	  for	  primary	  care	  physicians	  on	  opioid	  prescribing	  and	  pain	  management24.	  	  Third	  parties,	  such	  as	  Project	  Lazarus	  and	  certified	  continuing	  education	  firms,	  will	  provide	  the	  bulk	  of	  the	  training	  for	  this	  phase	  of	  the	  program.	  Hospital	  Emergency	  Departments	  (ED)	  must	  play	  an	  important	  role	  in	  management	  of	  opioid	  prescribing.	  	  Patients	  wishing	  to	  obtain	  opioids	  analgesics	  will	  often	  present	  to	  the	  ED	  hoping	  to	  quickly	  receive	  a	  prescription	  to	  continue	  abuse	  of	  the	  drug	  or	  for	  diversion.	  	  This	  program	  will	  encourage	  hospital	  administrators	  to	  modify	  policies	  and	  procedures	  to	  require	  ED	  physicians	  to:	  (1)	  consult	  the	  Controlled	  Substance	  Reporting	  System	  (CSRS)	  before	  prescribing	  opioids,	  (2)	  prescribe	  limited	  quantities,	  and	  (3)	  require	  follow	  up	  within	  a	  few	  days	  to	  obtain	  refills.	  	  A	  toolkit	  developed	  by	  CCNC	  Chronic	  Pain	  Initiative,	  specifically	  for	  ED	  physicians25,	  will	  form	  the	  basis	  of	  this	  advocacy	  campaign.	  Secondary	  prevention	  in	  the	  form	  of	  supply	  reduction	  and	  diversion	  control	  is	  achieved	  in	  several	  ways	  under	  this	  program.	  	  Provider	  education	  and	  increased	  use	  of	  prescriber	  guidelines	  should	  reduce	  the	  volume	  of	  extended	  release/long	  acting	  opioid	  analgesics	  prescribed	  to	  patients	  suffering	  from	  short-­‐term	  acute	  pain.	  	  In	  many	  cases	  these	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patients	  could	  be	  treated	  successfully	  using	  non-­‐opioid	  analgesics26,	  or	  by	  using	  short	  acting	  opioids	  and	  requiring	  follow	  up	  within	  a	  short	  time	  frame.	  	  Increased	  use	  of	  the	  CSRS	  will	  enable	  physicians	  to	  intervene	  earlier	  in	  the	  addiction	  cycle	  and	  discourage	  “doctor	  shopping”	  behavior	  on	  the	  part	  of	  patients.	  	  	  Overdose	  events	  are	  inevitable	  from	  licit	  and	  illicit	  usage	  of	  opioids.	  	  As	  I	  described	  in	  the	  literature	  review,	  the	  use	  of	  Naloxone	  has	  been	  shown	  to	  be	  an	  effective	  tool	  to	  prevent	  overdose	  death.	  	  Project	  Lazarus	  has	  developed	  a	  Naloxone	  “rescue	  kit”	  for	  use	  by	  family	  members	  in	  the	  event	  of	  an	  accidental	  overdose.	  	  The	  kit	  includes	  pre-­‐loaded	  syringes	  of	  Naloxone,	  an	  intranasal	  atomization	  device	  for	  administration	  of	  the	  drug,	  and	  illustrated	  instructions	  for	  use.	  	  Physicians	  prescribe	  the	  rescue	  kit	  to	  patients	  concurrently	  with	  the	  opioid	  medication,	  and	  families	  must	  be	  able	  to	  recognize	  the	  symptoms	  and	  administer	  the	  medication.	  Addiction	  treatment	  using	  Suboxone®	  (Buprenorphine)	  is	  a	  form	  of	  tertiary	  treatment	  for	  those	  patients	  who	  recognize	  their	  condition	  and	  wish	  to	  treat	  their	  dependency.	  	  Suboxone®	  is	  a	  synthetic	  opioid	  used	  to	  treat	  opioid	  addiction	  by	  reducing	  the	  severity	  of	  withdrawal	  symptoms	  by	  patients	  suffering	  from	  addiction.	  	  Side	  effects	  such	  as	  euphoria	  and	  respiratory	  depression	  are	  much	  less	  pronounced	  than	  those	  observed	  in	  users	  of	  heroine	  or	  methadone27.	  	  Suboxone®	  treatment	  may	  be	  conducted	  on	  an	  outpatient	  basis,	  thus	  reducing	  the	  stigma	  associated	  with	  traditional	  inpatient	  substance	  abuse	  regiments.	  	   Community-­‐based	  prevention	  education	  will	  emphasize	  the	  four	  “universal	  precautions”	  associated	  with	  safe	  opioid	  handling:	  
• Take	  correctly	  
Page	  |	  31	  
• Store	  securely	  
• Dispose	  properly	  
• Never	  share	  The	  coalition	  will	  develop	  appropriate	  promotional	  materials	  for	  display	  and	  distribution	  in	  physician	  practices,	  community	  events,	  public	  service	  announcements,	  and	  other	  venues.	  	  	  
Program	  Context	  	   The	  explosive	  growth	  in	  the	  use	  of	  opioid	  analgesics	  over	  the	  past	  20	  years	  has	  coincided	  with	  epidemic	  levels	  of	  morbidity	  and	  mortality	  from	  unintentional	  poisoning3.	  	  Misuse	  (non-­‐adherence	  with	  prescriber	  recommended	  dosage),	  abuse	  (i.e.,	  non-­‐medical,	  recreational	  use),	  and	  diversion	  of	  prescription	  opioids	  have	  contributed	  to	  this	  epidemic.	  	  Some	  areas	  of	  the	  state	  have	  been	  severely	  impacted;	  in	  Wilkes	  County,	  North	  Carolina	  the	  rate	  of	  overdose	  deaths	  was	  quadruple	  the	  statewide	  rate	  in	  2007-­‐200828.	  	  Nationwide,	  deaths	  from	  unintentional	  poisoning	  now	  exceed	  the	  number	  of	  deaths	  from	  motor	  vehicle	  accidents29.	  	  	  	   The	  medical	  community	  recognizes	  that	  the	  treatment	  of	  pain	  is	  a	  compelling	  priority	  in	  the	  practice	  of	  medicine.	  	  Patients	  in	  pain	  deserve	  access	  to	  safe	  and	  effective	  medication	  to	  provide	  relief	  and	  improve	  quality	  of	  life.	  	  Opioid	  analgesics	  are	  recognized	  internationally	  for	  their	  effectiveness	  in	  pain	  management;	  opioids	  have	  been	  placed	  on	  the	  World	  Health	  Organization’s	  list	  of	  Essential	  Medicines30.	  	  	  	  Compassionate	  providers	  wish	  to	  offer	  their	  patients	  the	  best	  solutions	  that	  medical	  science	  can	  provide;	  depriving	  patients	  of	  optimum	  pain	  relief	  options	  does	  them	  harm11.	  	  Policy	  analysts	  have	  observed	  that	  government	  may	  have	  overreached	  in	  an	  effort	  to	  mitigate	  the	  overdose	  problem	  at	  the	  expense	  of	  patients	  suffering	  in	  pain31.	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   The	  purpose	  of	  this	  program	  is	  to	  provide	  a	  balanced	  set	  of	  educational	  and	  surveillance	  tools	  to	  empower	  physicians,	  patients	  and	  the	  community	  the	  ability	  to	  make	  informed	  decisions	  regarding	  pain	  management.	  	  	  
Political	  Environment	  	   I	  conducted	  an	  informal	  Google	  search	  of	  “opioids”	  and	  “politics”	  and	  received	  “hits”	  for	  dozens	  of	  political	  and	  news	  stories	  detailing	  the	  dangers	  of	  opioid	  analgesics.	  	  Popular	  political	  news	  outlets	  such	  as	  Huffington	  Post,	  Reuters,	  CNN,	  Fox	  News,	  The	  Washington	  Post	  and	  others	  offer	  a	  flood	  of	  articles	  on	  the	  dangers	  of	  opioids.	  	  	  Interestingly	  the	  articles	  seem	  to	  cover	  a	  wide	  range	  of	  “expert”	  opinions;	  many	  tout	  the	  dangers	  of	  the	  epidemic	  while	  citing	  the	  thousands	  of	  deaths	  from	  overdose.	  	  Some	  “experts”	  advocate	  the	  need	  to	  find	  alternatives,	  while	  others	  lament	  the	  increased	  regulatory	  burden	  and	  restrictions	  on	  access	  by	  legitimate	  users.	  	  Other	  articles	  recommend	  “safety”	  measures	  such	  as	  the	  need	  for	  new	  labeling	  and	  advocate	  for	  access	  restriction	  by	  national	  chain	  pharmacies.	  	  Prescriptions	  painkillers	  such	  as	  OxyContin®	  are	  now	  in	  the	  public	  lexicon	  and	  are	  associated	  with	  abuse.	  	   Opioids	  are	  clearly	  on	  the	  “public	  agenda”	  after	  many	  years	  of	  obscurity.	  	  Politicians	  are	  eager	  to	  attack	  issues	  that	  resonate	  with	  the	  public,	  and	  the	  result	  has	  been	  reluctance	  on	  the	  part	  of	  physicians	  and	  pharmacies	  to	  provide	  opioids	  to	  patients	  in	  need	  of	  these	  critical	  medications.	  	  From	  a	  political	  perspective	  the	  timing	  is	  ideal	  for	  policy	  makers	  to	  make	  meaningful	  legislative	  and	  regulatory	  policy	  initiatives	  that	  could	  improve	  safety	  without	  limiting	  access.	  	  The	  potential	  for	  regulatory	  overreach	  also	  exists	  in	  the	  current	  climate	  where	  “opioids”	  are	  associated	  with	  substance	  abuse	  and	  overdose	  in	  the	  mind	  of	  the	  public.	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The	  elections	  of	  2010	  and	  2012	  brought	  sweeping	  changes	  to	  the	  political	  landscape	  of	  North	  Carolina	  at	  the	  local	  and	  state	  levels.	  	  At	  the	  state	  level	  the	  elections	  of	  2012	  led	  to	  a	  veto	  proof	  Republican	  super	  majority	  in	  the	  North	  Carolina	  General	  Assembly.	  	  The	  election	  of	  Republican	  Governor	  McCrory	  in	  2012	  ensured	  that	  conservative	  politics	  would	  dominate	  legislative	  priorities.	  	  The	  power	  of	  the	  super	  majority	  to	  dictate	  policy	  was	  highlighted	  recently	  by	  the	  legislative	  override	  of	  Governor	  McCrory’s	  veto	  of	  two	  high	  profile	  bills.	  	  However,	  the	  state	  population	  is	  not	  uniformly	  united	  behind	  the	  Republican	  policy	  platform.	  	  The	  “Moral	  Monday”	  protests	  saw	  thousands	  of	  participants	  congregate	  to	  the	  state	  capital	  to	  object	  to	  the	  conservative	  agenda;	  hundreds	  were	  arrested.	  	  	  At	  the	  state	  level	  Wilkes	  County	  is	  dominated	  by	  Republican	  control	  at	  all	  levels.	  	  State	  House	  Representatives	  Jeffrey	  Elmore	  (District	  94),	  Mark	  Hollo	  (District	  73),	  and	  Sarah	  Stevens	  (District	  90)	  are	  Republicans;	  as	  is	  State	  Senator	  Shirley	  Randleman	  of	  District	  30.	  	  	  At	  the	  local	  level,	  the	  five	  elected	  Wilkes	  County	  commissioners	  are	  Republicans.	  	  In	  summary	  the	  political	  atmosphere	  is	  characterized	  by	  a	  deeply	  partisan	  divide	  between	  conservative	  and	  progressive	  political	  forces,	  with	  the	  conservative	  forces	  holding	  tight	  control	  over	  the	  policy	  agenda.	  	  	  
Consistency	  with	  Local,	  State,	  and	  National	  Priorities	  	   At	  the	  national	  level,	  the	  Office	  of	  National	  Drug	  Control	  Policy	  (ONDCP)	  prepared	  a	  white	  paper	  in	  2011	  titled	  “Epidemic:	  	  Responding	  to	  America’s	  Prescription	  Drug	  Abuse	  Crisis”	  23.	  	  The	  white	  paper	  summarizes	  much	  of	  the	  statistical	  data	  regarding	  prescription	  drug	  abuse,	  which	  was	  taken	  from	  the	  National	  Survey	  on	  Drug	  Use	  and	  Health	  (NSDUH)	  32.	  	  NSDUH	  is	  an	  annual	  survey	  of	  approximately	  70,000	  individuals	  aged	  12	  or	  older	  and	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provides	  national	  and	  state-­‐level	  data	  on	  the	  use	  of	  tobacco,	  alcohol,	  illicit	  drugs	  and	  mental	  health	  in	  the	  U.S.	  	  In	  addition	  to	  the	  statistics	  provided	  in	  the	  NSDUH	  report,	  the	  white	  paper	  outlines	  the	  policy	  perspective	  of	  the	  current	  Administration	  and	  describes	  actions	  to	  be	  taken	  in	  four	  major	  areas	  to	  reduce	  prescription	  drug	  abuse	  and	  mortality:	  1. Education	  2. Tracking	  and	  Monitoring	  3. Proper	  Medication	  Disposal	  4. Enforcement	  The	  education,	  tracking,	  monitoring,	  and	  medication	  disposal	  programs	  outlined	  in	  the	  strategy	  are	  closely	  aligned	  with	  the	  program	  outlined	  in	  this	  paper.	  	  Education	  of	  providers	  and	  patients,	  increased	  use	  of	  the	  CSRS,	  and	  environmentally	  sound	  storage	  and	  disposal	  of	  medications	  are	  consistent	  with	  the	  guidance	  in	  the	  strategy	  paper.	  	  	   At	  the	  state	  level	  prevention	  of	  unintentional	  poisonings	  is	  a	  priority	  under	  the	  North	  Carolina	  Statewide	  Plan	  for	  Preventing	  Injuries	  and	  Violence33.	  	  The	  state	  Department	  of	  Health	  and	  Human	  Services	  (DHHS)	  created	  the	  Unintentional	  Poisoning	  Team	  with	  the	  mission	  of	  coordinating	  prevention	  efforts	  statewide.	  	  Partner	  organizations	  working	  with	  DHHS	  include	  Carolinas	  Poisoning	  Center;	  Community	  Care	  of	  North	  Carolina;	  The	  Governor’s	  Institute	  on	  Substance	  Abuse;	  Operation	  Medicine	  Cabinet	  and	  Operation	  Medicine	  Drop;	  Project	  Lazarus;	  UNC	  Injury	  Prevention	  Research	  Center;	  and	  others.	  	  The	  state	  is	  also	  partnering	  with	  national	  level	  organizations	  such	  as	  Safe	  State	  Alliance,	  the	  Council	  of	  State	  and	  Territorial	  Epidemiologists,	  and	  Substance	  Abuse	  and	  Mental	  Health	  Services	  Administration	  (SAMHSA).	  	  The	  goals	  outlined	  in	  the	  Statewide	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Plan,	  such	  as	  coalition	  building,	  surveillance,	  prevention	  programs,	  and	  training	  are	  consistent	  with	  the	  interventions	  in	  this	  paper.	  	   At	  the	  County	  level	  individual	  health	  departments	  in	  North	  Carolina	  are	  beginning	  the	  process	  of	  building	  coalitions	  to	  address	  the	  issue	  of	  prescription	  drug	  overdose.	  	  A	  major	  challenge	  at	  the	  local	  level	  is	  lack	  of	  resources	  and	  personnel	  to	  implement	  new	  programs	  in	  the	  face	  of	  declining	  budgets.	  	  The	  Project	  Lazarus	  program	  in	  Wilkes	  County	  is	  a	  good	  example	  of	  a	  locally	  developed	  intervention	  that	  used	  a	  multi-­‐level	  approach	  to	  successfully	  reduce	  overdose	  mortality	  rates.	  	  
Acceptability	  to	  Providers	  and	  Recipients	  	   The	  providers	  of	  the	  program	  are	  primary	  care	  and	  emergency	  department	  physicians,	  physician	  assistants,	  registered	  nurses,	  hospital	  staff,	  and	  other	  healthcare	  providers.	  	  This	  group	  of	  individuals	  will	  receive	  continuing	  education	  in	  opioid	  prescribing	  and	  will	  provide	  their	  patients	  with	  education	  and	  counseling	  in	  proper	  opioid	  use.	  	  My	  personal	  experience	  in	  many	  meetings	  with	  health	  care	  providers	  in	  various	  settings	  (hospitals,	  clinics,	  and	  during	  association	  meetings)	  has	  been	  very	  positive.	  	  Providers	  are	  well	  aware	  of	  the	  issue	  and	  they	  are	  anxious	  to	  hear	  solutions	  that	  could	  offer	  their	  patients	  with	  improved	  care.	  	  Many	  providers	  are	  not	  aware	  of	  the	  risk	  factors	  associated	  with	  opioid	  analgesics	  and	  they	  express	  a	  high	  level	  of	  interest	  in	  the	  topic.	  	  A	  common	  question	  I	  hear	  from	  providers	  at	  the	  conclusion	  of	  a	  meeting	  is	  “What	  can	  I	  do	  to	  help?”	  	  	   The	  recipients	  of	  the	  program	  include	  patients	  undergoing	  opioid	  therapy	  for	  pain	  management	  and	  the	  families	  of	  those	  patients.	  	  The	  program	  is	  minimally	  intrusive	  to	  patients	  or	  their	  families	  and	  offers	  an	  improved	  level	  of	  safety	  for	  all	  concerned.	  	  From	  a	  patient	  perspective	  the	  only	  change	  is	  the	  need	  for	  a	  pain	  management	  plan	  and	  perhaps	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more	  frequent	  follow-­‐ups	  with	  their	  primary	  care	  physician.	  	  	  This	  may	  present	  a	  problem	  for	  those	  without	  a	  primary	  care	  physician	  and	  therefore	  it	  is	  conceivable	  that	  those	  patients	  may	  experience	  greater	  difficulty	  accessing	  medications.	  	  The	  provisions	  of	  the	  Patient	  Protection	  and	  Affordable	  Care	  Act	  that	  provide	  subsidized	  health	  insurance	  to	  low	  income	  individuals	  and	  families	  will	  increase	  access	  to	  primary	  care	  and	  help	  to	  ameliorate	  this	  situation.	  	  Undocumented	  immigrants	  –	  who	  are	  not	  covered	  by	  the	  Affordable	  Care	  Act	  or	  by	  Medicaid	  -­‐	  may	  encounter	  more	  difficult	  access	  to	  opioid	  therapy	  due	  to	  more	  restrictive	  hospital	  emergency	  department	  policies	  
Financial	  Resources	  and	  Sustainability	  	   Financial	  requirements	  for	  implementation	  and	  management	  of	  the	  program	  are	  minimal;	  the	  principal	  resource	  is	  the	  need	  for	  a	  program	  manager	  and	  part-­‐time	  administrative	  aid	  within	  the	  local	  health	  department.	  	  Many	  health	  departments	  may	  delegate	  an	  existing	  employee	  –	  rather	  than	  hire	  a	  new	  employee	  -­‐	  to	  manage	  the	  start	  up	  and	  management	  of	  the	  program.	  	  This	  means	  the	  program(s)	  the	  employee	  was	  supporting	  must	  be	  reassigned	  elsewhere	  or	  deferred.	  	  This	  is	  both	  a	  financial	  and	  logistical	  challenge	  for	  many	  local	  health	  departments	  with	  limited	  budgets	  and	  personnel	  resources.	  	  	  In	  the	  current	  political	  climate	  in	  North	  Carolina	  the	  likelihood	  of	  increased	  state	  or	  local	  funding	  of	  new	  programs	  is	  very	  low.	  Grants	  are	  a	  potential	  source	  of	  funding	  for	  the	  program.	  	  The	  Kate	  B.	  Reynolds	  Charitable	  Trust	  and	  the	  State	  of	  North	  Carolina	  in	  April	  2013	  announced	  $2.6	  million	  in	  grant	  funding	  to	  support	  prescription	  drug	  abuse	  statewide34.	  	  Grant	  funds	  are	  inherently	  short-­‐term	  and	  not	  a	  sustainable	  source	  of	  funding.	  	  The	  level	  of	  effort	  needed	  to	  start-­‐up	  the	  program	  is	  much	  greater	  than	  the	  effort	  to	  sustain	  the	  program	  once	  it	  is	  implemented.	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Short	  term	  (e.g.,	  1-­‐2	  year)	  funding	  sources	  could	  therefore	  be	  sufficient	  to	  get	  the	  program	  “off	  the	  ground”	  and	  self-­‐sustaining.	  
Stakeholder	  Identification	  	   In	  this	  community-­‐based	  program	  stakeholders	  are	  the	  key	  to	  a	  successful	  intervention	  outcome.	  	  Stakeholders	  affect	  all	  stages	  of	  the	  program,	  are	  involved	  in	  the	  development	  and	  management	  of	  the	  program,	  and	  are	  more	  likely	  to	  support	  and	  sustain	  the	  program	  if	  they	  are	  involved	  in	  the	  entire	  process.	  	  Stakeholders	  can	  lend	  credibility	  to	  the	  program	  in	  the	  community	  through	  endorsement,	  involvement,	  and	  financial	  support.	  	   A	  key	  group	  of	  stakeholders	  in	  this	  program	  are	  primary	  care	  clinics	  in	  the	  local	  community,	  followed	  by	  hospitals	  and	  medical	  schools.	  	  The	  full	  support	  and	  endorsement	  from	  this	  group	  is	  critical	  to	  the	  success	  of	  the	  program.	  	  	  Another	  key	  group	  of	  stakeholders	  are	  patients	  and	  their	  families;	  the	  program	  depends	  highly	  on	  the	  voluntary	  support	  of	  this	  group.	  	   Secondary	  stakeholders	  are	  individuals	  or	  groups	  who	  are	  indirectly	  involved,	  provide	  support,	  or	  are	  affected	  by	  the	  program.	  	  This	  group	  includes	  organizations	  such	  as	  Community	  Care	  North	  Carolina35,	  The	  Chronic	  Pain	  Advisory	  Workgroup36,	  Northern	  Piedmont	  Community	  Care	  (Medicaid)	  37,	  Project	  Lazarus38,	  neighboring	  health	  departments,	  mental	  health	  care	  organizations,	  NC	  Department	  of	  Health	  and	  Human	  Services39,	  drug	  and	  opiate	  treatment	  clinics,	  church	  leaders,	  and	  public	  safety	  agencies	  (e.g.	  police,	  fire,	  EMS).	  	  Leaders	  from	  this	  group	  of	  secondary	  stakeholders	  will	  be	  recruited	  for	  the	  community	  coalition.	  	   News	  media	  are	  a	  key	  stakeholder	  that	  can	  have	  a	  profound	  influence	  on	  the	  success	  or	  failure	  of	  the	  program.	  	  Although	  the	  media	  will	  not	  be	  a	  member	  of	  the	  coalition	  group	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who	  will	  manage	  the	  program,	  the	  coalition	  leadership	  must	  forge	  a	  positive	  working	  relationship	  with	  members	  of	  media	  organizations.	  	  Media	  friendly	  announcements,	  press	  releases	  and	  other	  communications	  are	  an	  important	  element	  of	  the	  program.	  
Program	  Theory	  	   The	  Ecological	  Model	  of	  Health	  Behavior	  forms	  the	  basis	  for	  the	  program	  theory	  in	  this	  intervention.	  	  The	  ecological	  model	  emphasizes	  the	  environmental	  and	  policy	  contexts	  of	  behavior,	  and	  recognizes	  that	  behavior	  has	  multiple	  levels	  of	  influence	  including	  the	  intrapersonal,	  interpersonal,	  organizational,	  community	  and	  policy	  levels40.	  	  This	  program	  features	  interventions	  at	  the	  intrapersonal,	  organizational,	  and	  community	  levels	  of	  the	  ecological	  model.	  	  Provider	  education	  of	  patients	  is	  intended	  to	  intervene	  at	  the	  intrapersonal	  and	  interpersonal	  levels	  by	  enhancing	  self-­‐efficacy.	  	  Modification	  of	  opioid	  prescribing	  procedures	  by	  individual	  providers	  and	  emergency	  departments	  impacts	  the	  health	  issue	  at	  the	  organizational	  level	  of	  the	  model.	  	  Coalition	  building	  addresses	  the	  overdose	  issue	  at	  the	  community	  level	  through	  development	  of	  community	  capacity,	  participation,	  relevance,	  and	  engagement.	  	  	   The	  Health	  Belief	  Model	  (HBM)	  41	  operates	  at	  the	  intrapersonal	  level	  of	  the	  ecological	  model	  and	  stresses	  the	  importance	  of	  awareness	  and	  insight	  by	  an	  individual	  taking	  responsibility	  for	  their	  own	  health.	  	  Perceived	  susceptibility,	  perceived	  severity,	  perceived	  benefits,	  perceived	  barriers,	  cues	  to	  action,	  and	  self-­‐efficacy	  constitute	  the	  six	  constructs	  of	  the	  HBM.	  	  The	  interaction	  of	  these	  constructs	  within	  the	  mind	  of	  the	  individual	  provides	  a	  basis	  to	  predict	  why	  people	  will	  take	  action	  to	  prevent,	  screen	  for,	  or	  control	  an	  illness	  condition.	  	  A	  major	  component	  of	  this	  intervention	  involves	  providers	  offering	  their	  patients	  education	  in	  the	  safe	  use,	  storage,	  and	  disposal	  of	  opioids,	  and	  the	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risks	  associated	  with	  improper	  use	  of	  these	  medications.	  	  Perceived	  susceptibility,	  perceived	  severity,	  and	  self-­‐efficacy	  are	  relevant	  in	  this	  intervention,	  as	  the	  goal	  of	  the	  education	  component	  is	  to	  motivate	  patients	  to	  modify	  their	  behavior	  on	  the	  basis	  of	  newfound	  risk	  and	  vulnerability.	  	  Increased	  knowledge	  of	  their	  personal	  vulnerability	  and	  the	  potential	  for	  harm	  to	  family	  members	  may	  motivate	  patients	  to	  heed	  the	  advice	  of	  health	  care	  providers.	  	  Self-­‐efficacy	  also	  comes	  into	  play,	  as	  the	  advice	  offered	  is	  well	  within	  the	  capability	  of	  the	  patient	  to	  follow,	  thus	  instilling	  the	  conviction	  in	  the	  mind	  of	  the	  patient	  that	  she	  can	  successfully	  execute	  the	  behavior.	  	   Coalition	  building	  is	  a	  critical	  component	  of	  this	  intervention;	  the	  Community	  
Coalition	  Action	  Theory	  (CCAT)	  offers	  a	  framework	  through	  which	  community	  stakeholders	  build	  consensus	  and	  actively	  engage	  diverse	  constituencies	  in	  addressing	  community	  issues	  and	  problems42.	  	  	  Under	  the	  CCAT	  a	  coalition	  may	  be	  formed	  to	  promote	  a	  health	  agenda,	  prevent	  disease,	  or	  address	  a	  community	  problem	  by	  analyzing	  the	  issue	  and	  implementing	  strategies	  for	  change.	  	  Participation	  in	  a	  coalition	  facilitates	  ownership	  among	  stakeholders,	  builds	  community	  capacity,	  and	  develops	  competence	  among	  coalition	  members.	  	  CCAT	  describes	  the	  stages	  of	  coalition	  development,	  coalition	  functioning,	  and	  creation	  of	  organizational	  and	  community	  changes	  that	  can	  lead	  to	  improved	  outcomes.	  	  Some	  of	  the	  relevant	  constructs	  of	  the	  CCAT	  include	  stages	  of	  development;	  community	  context;	  lead	  agency/convener	  group;	  leadership	  and	  staffing;	  pooled	  member	  and	  external	  resources;	  implementation	  strategies;	  and	  community	  capacity.	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Goals	  and	  Objectives	  	   Based	  on	  results	  from	  national	  and	  state	  level	  surveillance	  data	  the	  goal	  of	  this	  program	  is	  to	  reduce	  the	  incidence	  of	  unintentional	  overdose	  deaths	  attributed	  to	  prescription	  opioid	  analgesics.	  	  The	  objectives	  and	  activities	  associated	  with	  the	  goal	  are	  summarized	  in	  the	  program	  logic	  model	  illustrated	  in	  Figure	  1.	  	  	  
Short	  Term	  Objectives	  (1-­‐3	  years)	  
Short-­‐Term	  Objective	  1:	  	  By	  month	  six,	  the	  Health	  Department	  Program	  Manager	  (PM)	  will	  assemble	  a	  working	  coalition	  of	  physicians,	  healthcare	  executives,	  public	  health	  officials,	  and	  community	  leaders.	  	  The	  assembled	  coalition	  will	  create	  a	  vision	  and	  mission	  statement	  and	  develop	  a	  set	  of	  rules	  for	  decision-­‐making	  and	  dispute	  resolution.	  
Activities:	  	  The	  PM	  will	  schedule	  appointments	  and	  meet	  face	  to	  face	  with	  leading	  physicians	  and	  community	  leaders;	  attend	  town	  hall	  meetings;	  speak	  at	  civic	  organizations;	  participate	  in	  public	  health	  task	  forces;	  and	  engage	  in	  other	  networking	  opportunities	  to	  discuss	  the	  overdose	  problem.	  	  These	  forums	  will	  be	  used	  to	  qualify	  and	  recruit	  stakeholders	  to	  the	  coalition.	  
Short-­‐Term	  Objective	  2:	  	  By	  the	  end	  of	  year	  two,	  the	  coalition	  membership	  will	  make	  contact	  with	  75%	  of	  the	  primary	  care	  physician	  practices	  and	  dental	  care	  practices	  in	  the	  county;	  50%	  of	  those	  physicians/dentists	  will	  have	  received	  opioid	  prescriber	  training,	  either	  via	  one-­‐on-­‐one	  or	  third	  party	  continuing	  medical	  education.	  	  
Activities:	  	  The	  PM	  or	  designee	  will	  create	  a	  tracking	  database	  containing	  the	  contact	  information	  for	  each	  physician/dentists	  in	  the	  county.	  	  The	  PM	  will	  coordinate	  with	  the	  coalition	  membership	  to	  develop	  a	  plan	  to	  contact	  physicians,	  develop	  a	  unified	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message	  for	  meetings,	  and	  assign	  coalition	  members	  a	  list	  of	  physicians	  to	  contact.	  	  The	  PM	  will	  document	  the	  results	  of	  each	  contact	  in	  the	  database	  and	  recommend	  follow	  up	  actions.	  	  
Short-­‐Term	  Objective	  3:	  	  By	  the	  end	  of	  year	  three,	  50%	  of	  emergency	  departments	  in	  the	  county	  will	  have	  updated	  their	  opioid	  analgesic	  prescribing	  policies	  and	  procedures	  to	  reflect	  current	  best	  practices.	  
Activities:	  	  The	  PM	  will	  work	  with	  hospital	  administrators	  in	  the	  coalition	  to	  review	  existing	  opioid	  prescribing	  procedures	  in	  local	  hospitals	  and	  create	  a	  “model”	  set	  of	  policies	  and	  procedures	  consistent	  with	  best	  practices.	  	  
Short-­‐Term	  Objective	  4:	  By	  the	  end	  of	  year	  three,	  a	  Naloxone	  rescue	  kit	  will	  accompany	  50%	  of	  new	  prescriptions	  for	  long-­‐term	  opioid	  analgesics.	  
Activities:	  	  Introduce	  the	  Naloxone	  training	  kit	  during	  the	  opioid	  prescriber	  training	  course,	  and	  reinforce	  the	  importance	  of	  the	  kit	  during	  face-­‐to-­‐face	  and	  group	  meetings	  with	  healthcare	  providers.	  
Long-­‐Term	  Objectives	  (3-­‐5	  years)	  
Long-­‐Term	  Objective	  1:	  	  By	  the	  end	  of	  year	  three	  in	  the	  targeted	  county,	  there	  will	  be	  a	  25%	  reduction	  in	  the	  overdose	  death	  rate	  attributable	  to	  prescription	  opioid	  analgesics.	  
Activities:	  	  The	  PM	  will	  determine	  the	  baseline	  rate	  for	  unintentional	  overdose,	  maintain	  surveillance	  over	  the	  course	  of	  the	  intervention,	  and	  report	  the	  results	  for	  the	  mortality	  rate	  annually.	  
Long-­‐Term	  Objective	  2:	  	  By	  the	  end	  of	  year	  five,	  less	  than	  10%	  of	  deaths	  from	  unintentional	  overdose	  will	  be	  attributed	  to	  substances	  prescribed	  by	  a	  county	  physician.	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Long-­‐Term	  Objective	  3:	  	  By	  the	  end	  of	  year	  four,	  the	  number	  of	  physicians	  and	  pharmacists	  using	  the	  CSRS	  will	  increase	  by	  25%.	  
Long-­‐Term	  Objective	  4:	  	  By	  year	  five,	  50%	  of	  patients	  on	  long-­‐term	  opioid	  therapy	  for	  chronic	  pain	  will	  be	  under	  the	  guidance	  of	  a	  patient-­‐prescriber	  agreement.	  	  
Implementation	  A	  timeline	  for	  program	  activities	  is	  summarized	  in	  Table	  3.	  	  Implementation	  of	  the	  program	  begins	  with	  the	  hiring	  and	  appointment	  of	  a	  Program	  Manager	  by	  the	  Health	  Department	  Director.	  	  The	  PM	  may	  be	  an	  existing	  member	  of	  the	  health	  department	  staff	  or	  a	  new	  hire	  with	  multiple	  responsibilities	  and	  duties	  within	  the	  department.	  	  Objective	  1,	  recruitment	  and	  assembly	  of	  a	  working	  coalition	  to	  support	  and	  guide	  the	  program,	  is	  the	  first	  task	  assigned	  to	  the	  PM.	  	  Locating	  qualified	  coalition	  members	  begins	  with	  an	  assessment	  of	  the	  organizations	  and	  individuals	  who	  have	  a	  current	  working	  relationship	  with	  the	  health	  department,	  and	  particularly	  the	  Health	  Director.	  	  Other	  management	  staff	  within	  the	  department	  –	  such	  as	  the	  Medical	  Director,	  Health	  Education	  supervisor,	  Clinical	  Staff	  supervisor,	  WIC	  staff	  supervisor	  –	  will	  have	  many	  external	  contacts	  who	  may	  be	  a	  good	  fit	  as	  potential	  coalition	  members.	  	  Another	  resource	  pool	  are	  members	  of	  the	  Board	  of	  Health,	  who	  are	  typically	  a	  very	  diverse	  group	  with	  good	  skill	  sets,	  natural	  leadership	  potential,	  and	  demonstrated	  enthusiasm	  for	  public	  health.	  	  Tapping	  into	  this	  “built-­‐in”	  resource	  for	  coalition	  partners	  is	  an	  essential	  first	  step	  for	  the	  PM.	  	   Development	  of	  a	  vision	  and	  mission	  statement	  is	  the	  first	  order	  of	  business	  for	  the	  newly	  assembled	  coalition-­‐working	  group	  and	  is	  incorporated	  into	  Objective	  1.	  	  The	  coalition	  will	  struggle	  for	  direction	  without	  the	  guidance	  of	  a	  clear	  mission,	  and	  the	  driving	  force	  of	  an	  idealistic	  yet	  achievable	  vision.	  	  Additionally	  the	  coalition	  must	  agree	  to	  a	  clear	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set	  of	  rules	  to	  guide	  decision-­‐making	  and	  dispute	  resolution.	  	  Strong	  and	  flexible	  leadership	  must	  be	  exercised	  by	  the	  PM	  to	  ensure	  the	  voices	  and	  perspectives	  of	  all	  coalition	  members	  are	  recognized	  and	  respected.	  	   Objective	  2,	  establishing	  contact	  with	  the	  primary	  care	  providers	  in	  the	  County,	  is	  the	  next	  activity	  on	  the	  project	  timeline.	  	  Coalition	  members	  are	  likely	  to	  have	  extensive	  contacts	  within	  the	  physician	  community;	  the	  PM	  or	  designee	  must	  create	  a	  database	  of	  primary	  care	  and	  dental	  practices.	  	  The	  database	  must	  be	  capable	  of	  capturing	  not	  only	  demographic	  information,	  but	  must	  also	  have	  the	  ability	  to	  record	  meeting	  outcomes	  and	  follow	  up	  actions.	  	  The	  database	  has	  the	  dual	  function	  of	  aiding	  in	  the	  operational	  phase	  of	  the	  implementation	  and	  providing	  raw	  data	  for	  the	  evaluation	  phase.	  	  Concurrent	  with	  this	  activity	  is	  assembly	  of	  hardcopy	  and	  electronic	  Prescriber	  Tool	  Kits24	  for	  the	  purposes	  of	  provider	  education	  and	  training,	  and	  Naloxone	  rescue	  kits	  for	  demonstration	  purposes.	  	   Provider	  education,	  a	  component	  of	  Objective	  2,	  will	  take	  place	  either	  via	  one-­‐on-­‐one	  training	  by	  a	  qualified	  coalition	  member	  or	  from	  a	  third	  party	  continuing	  education	  provider.	  	  Qualified	  coalition	  members	  –	  preferably	  primary	  care	  physicians	  themselves	  –	  must	  be	  selected,	  and	  a	  unified	  presentation	  developed	  to	  ensure	  a	  consistent	  training	  program	  is	  delivered	  to	  all	  providers.	  	  Some	  providers	  will	  prefer	  to	  obtain	  training	  as	  part	  of	  their	  continuing	  medical	  education	  requirements.	  	  Coordination	  and	  scheduling	  with	  a	  third	  party	  continuing	  education	  provider	  –	  such	  as	  Community	  Care	  North	  Carolina35	  or	  Northern	  Piedmont	  Community	  Care37	  -­‐	  must	  be	  arranged	  by	  the	  PM	  or	  designee.	  	  	  	   Modification	  of	  emergency	  department	  opioid	  prescribing	  policies	  and	  procedures,	  Objective	  3,	  must	  begin	  with	  a	  general	  discussion	  with	  hospital	  executive	  management.	  	  Ideally	  a	  local	  hospital	  administrator	  will	  be	  a	  part	  of	  the	  coalition;	  the	  next	  best	  option	  is	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to	  find	  a	  coalition	  member	  who	  has	  a	  professional	  relationship	  with	  a	  hospital	  manager	  and	  enlist	  this	  person	  to	  begin	  the	  discourse.	  	  If	  coalition	  members	  are	  available	  who	  have	  experience	  with	  hospital	  policies	  and	  procedures,	  these	  member(s)	  should	  be	  enlisted	  to	  prepare	  a	  set	  of	  “model”	  opioid	  prescribing	  procedures.	  	  	  	   Inclusion	  of	  Naloxone	  rescue	  kits	  to	  accompany	  opioid	  prescriptions	  for	  patients	  with	  risk	  factors	  for	  overdose	  is	  part	  of	  Objective	  4.	  Naloxone	  rescue	  kits	  include	  a	  preloaded	  syringe,	  which	  must	  be	  affixed	  to	  a	  mucosal	  atomizer	  before	  the	  medication	  can	  be	  administered	  to	  an	  unresponsive	  patient.	  	  In	  order	  to	  successfully	  revive	  an	  overdose	  victim	  the	  family	  member	  must:	  (1)	  recognize	  the	  sign	  and	  symptoms	  of	  overdose;	  (2)	  assemble	  the	  syringe/atomizer;	  (3)	  correctly	  administer	  the	  medication;	  (4)	  place	  the	  victim	  in	  the	  rescue	  position;	  and	  (5)	  call	  911.	  	  By	  definition	  an	  overdose	  victim	  is	  in	  a	  life-­‐threatening	  condition,	  and	  family	  members	  will	  be	  under	  extreme	  stress.	  	  Family	  members	  must	  receive	  some	  minimum	  level	  of	  training	  to	  improve	  the	  odds	  that	  the	  symptoms	  will	  be	  recognized	  and	  the	  medication	  correctly	  administered.	  	  The	  coalition	  must	  develop	  a	  training	  protocol	  for	  family	  members/caregivers	  to	  support	  this	  component	  of	  the	  intervention.	  	   Improvements	  in	  provider	  pain	  management	  skills,	  and	  better	  awareness	  among	  patients	  of	  the	  risks	  of	  opioid	  medications	  are	  expected	  to	  reduce	  overall	  overdose	  mortality	  attributable	  to	  prescription	  opioids	  (long	  term	  Objectives	  5	  and	  6).	  	  Objective	  7,	  increased	  utilization	  of	  the	  CSRS,	  will	  occur	  following	  initial	  education	  and	  with	  continued	  follow	  up	  messaging.	  	  Similarly	  Objective	  8	  –	  more	  frequent	  use	  of	  pain	  management	  plans	  –	  will	  require	  ongoing	  education	  efforts.	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Resources	  and	  Budget	  A	  detailed	  annual	  program	  budget	  is	  provided	  in	  Figure	  3.	  	  Budget	  line	  items	  are	  discussed	  below.	  
Program	  Manager:	  	  The	  duties	  of	  the	  PM	  are	  to	  recruit	  the	  coalition	  members,	  provide	  leadership	  for	  the	  coalition-­‐working	  group,	  create	  and	  manage	  the	  program	  database,	  meet	  with	  stakeholders,	  promote	  the	  program	  to	  the	  community,	  advocate	  for	  change,	  and	  garner	  financial	  support.	  	  These	  activities	  will	  initially	  require	  a	  full	  time	  commitment	  for	  the	  first	  year	  of	  the	  program.	  	  Afterward	  the	  program	  will	  become	  more	  self-­‐sustaining	  and	  the	  full	  time	  commitment	  can	  be	  reduced.	  
Administrative	  Support:	  	  The	  PM	  will	  require	  administrative	  support	  for	  document	  creation,	  database	  management,	  scheduling,	  travel,	  procurement	  and	  other	  activities.	  	  This	  can	  be	  an	  existing	  health	  department	  employee.	  	  A	  25%	  Full	  Time	  Equivalent	  (FTE)	  is	  the	  expected	  support	  requirement.	  
Travel/Transportation:	  	  Travel	  within	  the	  County	  and	  in	  the	  adjoining	  Counties	  to	  attend	  meetings	  and	  confer	  with	  stakeholders	  will	  be	  frequent	  during	  the	  first	  year	  of	  implementation.	  	  Off	  site	  training	  and	  attendance	  to	  conferences	  and	  symposia	  may	  also	  entail	  overnight	  travel.	  	  Expenses	  will	  include	  mileage,	  airfare,	  lodging,	  per	  diem,	  meals,	  and	  incidental	  expenses	  (M&IE).	  
Equipment	  &	  Supplies:	  	  The	  PM	  will	  require	  a	  laptop	  computer	  and	  portable	  projector	  for	  conducting	  presentations.	  	  General	  office	  supplies	  for	  correspondence	  and	  project	  files	  must	  be	  allocated.	  	  A	  third	  party	  vendor	  for	  printing/binding	  services	  to	  prepare	  professional	  quality	  training	  and	  promotional	  materials	  will	  also	  be	  required.	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Training/Consulting:	  	  Off	  site	  training	  services	  may	  be	  contracted	  to	  offer	  coalition	  members	  an	  opportunity	  to	  increase	  their	  knowledge	  and	  background.	  	  A	  third	  party	  consulting	  firm	  will	  also	  be	  retained	  to	  conduct	  an	  annual	  evaluation	  of	  the	  program	  activities	  and	  provide	  continuous	  quality	  improvement	  to	  ensure	  goals	  and	  objectives	  are	  achieved.	  	  	  	  	  
Miscellaneous:	  	  Food	  and	  refreshments	  for	  coalition	  working-­‐group	  meetings,	  training	  sessions,	  and	  events	  will	  be	  provided.	  	  Off-­‐site	  coalition	  meetings	  may	  occasionally	  be	  scheduled	  and	  will	  incur	  charges	  for	  conference	  room	  accommodations.	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Evaluation	  Plan	  
Rationale	  and	  Approach	  to	  the	  Evaluation	  	   Program	  evaluation	  is	  an	  indispensable	  component	  of	  an	  effective	  public	  health	  intervention.	  	  An	  evaluation	  plan	  is	  a	  document	  that	  describes	  how	  the	  health	  intervention	  program	  will	  be	  monitored	  and	  how	  the	  evaluation	  results	  will	  be	  used43.	  This	  evaluation	  plan	  will	  examine	  process	  metrics	  (the	  intermediate	  steps	  associated	  with	  implementing	  the	  program)	  and	  outcome	  metrics	  	  (the	  impact	  on	  the	  health	  issue	  we	  are	  trying	  to	  influence).	  	  To	  place	  the	  evaluation	  in	  the	  proper	  context	  I	  will	  describe	  why	  the	  evaluation	  is	  being	  conducted,	  who	  will	  conduct	  the	  evaluation,	  expectations	  of	  stakeholders	  and	  funders,	  and	  difficulties	  that	  the	  evaluator	  may	  experience	  in	  the	  course	  of	  the	  evaluation.	  	   The	  primary	  reasons	  for	  the	  program	  evaluation	  are	  to	  strengthen	  the	  program,	  to	  create	  a	  participatory	  process	  among	  the	  stakeholders,	  allow	  for	  flexibility,	  and	  to	  support	  accountability.	  	  The	  evaluation	  plan	  will	  serve	  a	  number	  of	  interrelated	  purposes.	  	  	  The	  process	  evaluation	  component	  of	  the	  plan	  will	  provide	  the	  raw	  data	  to	  support	  management	  of	  the	  start	  up	  and	  operations	  phases	  of	  the	  program.	  	  The	  PM	  will	  use	  data	  from	  the	  process	  evaluation	  to	  update	  timelines,	  track	  progress	  relative	  to	  internally	  established	  goals,	  and	  ensure	  milestones	  are	  reached	  on	  schedule.	  	  This	  will	  foster	  program	  transparency	  to	  stakeholders,	  encourage	  engagement	  from	  the	  coalition	  members,	  and	  facilitate	  preparation	  of	  progress	  reports	  to	  funding	  organizations.	  	  The	  results	  gleaned	  from	  the	  process	  and	  outcome	  evaluations	  will	  be	  used	  to	  guide	  the	  coalition	  in	  making	  changes	  to	  improve	  the	  effectiveness	  of	  the	  implementation.	  	  Outcome	  data	  will	  help	  establish	  evidence	  for	  a	  causal	  association	  between	  the	  program	  and	  improved	  outcomes;	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these	  data	  may	  be	  used	  to	  guide	  transfer	  of	  the	  program	  to	  other	  geographic	  locations	  in	  North	  Carolina.	  	  	   	   The	  primary	  evaluator	  for	  this	  intervention	  is	  the	  Program	  Manager	  (PM),	  who	  will	  take	  an	  interactive	  and	  participatory	  role	  in	  the	  program.	  	  The	  PM	  will	  engage	  with	  program	  staff	  and	  stakeholders	  throughout	  the	  evaluation	  process,	  and	  will	  actively	  work	  to	  promote	  continuous	  improvement	  in	  the	  program	  for	  the	  duration	  of	  the	  intervention.	  	  A	  challenge	  facing	  the	  program	  is	  the	  limited	  amount	  of	  dedicated	  staffing	  available	  for	  program	  implementation;	  the	  program	  envisions	  one	  full	  time	  Program	  Manager	  and	  a	  part	  time	  Administrative	  Aide.	  	  To	  leverage	  limited	  personnel	  resources	  the	  PM	  will	  engage	  the	  services	  of	  an	  external	  consultant	  who	  will	  provide	  technical	  support	  and	  expertise.	  	  The	  internal	  evaluator	  (PM)	  brings	  first	  hand	  knowledge	  of	  the	  program,	  familiarity	  with	  community	  members,	  and	  has	  more	  opportunities	  for	  informal	  feedback	  with	  	  	  stakeholders44.	  	  The	  external	  evaluator	  will	  bring	  broad	  evaluation	  expertise,	  a	  detached,	  objective	  perspective,	  and	  an	  unbiased	  view	  of	  the	  program’s	  strengths	  and	  weaknesses.	  	  	  	   	   The	  key	  skills	  expected	  for	  the	  evaluation	  team	  include	  the	  ability	  to	  listen	  to	  the	  input	  and	  concerns	  of	  program	  staff	  and	  stakeholders;	  the	  ability	  to	  negotiate;	  and	  the	  ability	  to	  bring	  together	  multiple	  perspectives	  from	  the	  community	  to	  the	  evaluation44.	  	  Skills	  relevant	  to	  the	  intervention	  also	  include	  public	  presentation	  skills,	  media	  handling,	  team	  building,	  and	  conflict	  resolution.	  Integrity,	  clear	  ethical	  sense,	  and	  honesty	  are	  important	  personal	  characteristics	  that	  the	  evaluator	  must	  possess	  to	  provide	  evaluations	  that	  have	  the	  features	  of	  utility,	  feasibility,	  propriety,	  and	  accuracy45.	  	   End	  users	  of	  evaluation	  results	  include	  the	  PM,	  coalition	  members,	  stakeholders,	  media	  organizations,	  and	  by	  extension,	  the	  general	  public.	  	  Process	  evaluation	  results	  that	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guide	  implementation	  and	  operations	  are	  generally	  limited	  to	  the	  PM	  and	  coalition	  group,	  who	  carry	  the	  responsibility	  for	  managing	  the	  program.	  	  Outcome	  results	  will	  receive	  broader	  distribution	  and	  interest.	  	  Recipients	  of	  evaluation	  results	  will	  be	  concerned	  with	  a	  range	  of	  issues:	  
• Are	  the	  resources	  assigned	  to	  the	  program	  sufficient?	  
• Are	  goals	  and	  milestones	  achieved	  on	  schedule?	  
• Is	  the	  program	  being	  managed	  effectively?	  Transparency,	  accountability	  and	  stakeholder	  engagement	  can	  be	  enhanced	  by	  inclusion	  of	  stakeholder	  groups	  during	  the	  evaluation	  planning	  and	  implementation	  process.	  	  An	  option	  to	  achieve	  this	  aim	  is	  to	  form	  an	  evaluation	  subcommittee	  comprised	  of	  coalition	  members	  and	  selected	  stakeholders,	  who	  will	  then	  be	  responsible	  for	  various	  elements	  of	  the	  evaluation	  such	  as	  data	  collection,	  database	  creation,	  data	  processing,	  and	  dissemination	  of	  results.	  	  	  	   The	  evaluation	  team	  will	  encounter	  numerous	  challenges	  while	  working	  to	  achieve	  the	  objectives	  of	  the	  evaluation	  plan.	  	  Chief	  among	  those	  challenges	  are	  budgetary	  limitations,	  followed	  by	  time	  constraints,	  data	  availability,	  technical	  skills	  (e.g.,	  database	  management),	  competing	  priorities	  among	  coalition	  members,	  and	  differing	  expectations	  among	  stakeholders46,47.	  	  Political	  influences	  also	  have	  the	  potential	  to	  impact	  the	  evaluation	  process;	  politically	  conservative	  stakeholders	  may	  perceive	  that	  prevention	  programs	  affecting	  injection	  drug	  users	  are	  not	  socially	  desirable.	  	  Limited	  staffing	  will	  also	  present	  a	  challenge;	  the	  PM	  is	  responsible	  for	  concurrently	  managing	  the	  program	  implementation	  and	  leading	  the	  evaluation	  effort.	  	  Her	  time	  will	  be	  very	  limited	  during	  the	  start	  up	  phase,	  and	  the	  risk	  is	  that	  important	  aspects	  of	  the	  evaluation	  plan	  will	  be	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deferred.	  	  Instrumentation	  design	  challenges	  (surveys,	  questionnaires),	  low	  survey	  response	  rates,	  and	  respondent’s	  reluctance	  to	  divulge	  sensitive	  information	  may	  negatively	  affect	  the	  outcome	  evaluation.	  	   The	  challenges	  faced	  by	  the	  evaluation	  team	  are	  best	  addressed	  through	  frank	  and	  open	  discussion	  of	  these	  difficulties	  with	  the	  coalition	  membership.	  	  Maintaining	  an	  ongoing	  line	  of	  communications	  will	  allow	  the	  combined	  skills	  and	  experience	  of	  the	  team	  to	  bear	  on	  the	  problem	  and	  enable	  solutions	  to	  evolve.	  	  An	  important	  resource	  for	  the	  evaluation	  team	  is	  the	  third	  party	  evaluator;	  this	  specialist	  will	  possess	  technical	  skills	  and	  knowledge	  that	  will	  prove	  useful.	  	  Team	  leadership	  skills	  on	  the	  part	  of	  the	  PM	  are	  crucial	  to	  the	  task	  of	  bringing	  the	  evaluation	  team	  together	  and	  overcoming	  the	  inevitable	  obstacles	  that	  will	  appear	  over	  the	  course	  of	  the	  program	  timeline.	  
Evaluation	  Study	  Design	  Program	  evaluation	  may	  take	  many	  forms	  and	  levels	  of	  complexity	  depending	  upon	  the	  needs	  of	  the	  stakeholders,	  participants,	  funders,	  and	  program	  staff.	  	  Researchers	  who	  wish	  to	  unequivocally	  demonstrate	  causality	  may	  employ	  rigorous	  experimental	  designs	  using	  randomized	  subjects	  and	  controls47.	  	  This	  type	  of	  outcome	  evaluation	  minimizes	  threats	  to	  internal	  and	  external	  validity,	  but	  normally	  requires	  approval	  by	  an	  Institutional	  Review	  Board	  (IRB)	  and	  is	  the	  most	  costly	  and	  time-­‐consuming	  evaluation	  to	  perform.	  	  Conversely,	  programs	  where	  stakeholders	  have	  little	  interest	  in	  causality	  may	  opt	  for	  an	  outcome	  documentation	  evaluation	  utilizing	  a	  “one-­‐group	  posttest	  only”	  design	  with	  no	  pretest	  or	  controls.	  	  An	  outcome	  documentation	  evaluation	  offers	  no	  link	  to	  a	  causal	  relationship	  but	  is	  the	  simplest	  and	  most	  cost-­‐effective	  evaluation.	  	  The	  intermediate	  level	  of	  evaluation	  is	  an	  outcome	  assessment	  evaluation,	  which	  answers	  the	  question	  of	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whether	  the	  program	  had	  a	  measurable	  effect	  on	  the	  health	  outcome,	  for	  individuals	  who	  were	  exposed	  to	  the	  intervention47.	  	  I	  have	  selected	  a	  quasi-­‐experimental,	  non-­‐randomized,	  interrupted	  time-­‐series	  design	  with	  a	  non-­‐equivalent	  no-­‐treatment	  control	  group	  to	  evaluate	  the	  effect	  of	  the	  program.	  	  This	  design	  is	  intended	  to	  support	  an	  outcome	  assessment	  evaluation,	  which	  is	  the	  intermediate	  level	  of	  evaluation	  as	  described	  in	  the	  preceding	  paragraph.	  	  In	  a	  time-­‐series	  design	  measurements	  are	  taken	  on	  the	  same	  variable	  (e.g.,	  prescription	  opioid	  mortality	  rate)	  consecutively	  over	  time48.	  	  An	  interrupted	  time-­‐series	  design	  allows	  for	  assessment	  of	  treatment	  impact	  because	  in	  this	  type	  of	  study	  the	  specific	  point	  in	  the	  series	  when	  the	  intervention	  takes	  place	  is	  known.	  	  Therefore	  measurements	  taken	  after	  the	  intervention	  will	  exhibit	  a	  different	  slope	  or	  level,	  if	  the	  intervention	  had	  an	  effect	  on	  the	  health	  outcome.	  	  The	  non-­‐equivalent	  no-­‐treatment	  control	  group	  will	  be	  comprised	  of	  a	  randomly	  selected	  county	  in	  North	  Carolina	  with	  similar	  demographics	  to	  the	  “experimental”	  county.	  	  Inclusion	  of	  a	  no-­‐treatment	  control	  is	  intended	  to	  build	  a	  stronger	  causal	  inference	  to	  the	  study.	  	  	   The	  interrupted	  time-­‐series	  design	  is	  a	  strong	  quasi-­‐experimental	  alternative	  to	  an	  experimental	  design;	  however,	  threats	  to	  validity	  are	  increased	  versus	  the	  experimental	  model.	  	  The	  major	  threat	  is	  history	  –	  the	  possibility	  that	  factors	  other	  than	  the	  intervention	  influenced	  the	  outcome	  variable	  during	  the	  period(s)	  when	  the	  intervention	  was	  implemented48.	  	  Selection	  bias	  is	  another	  potential	  threat;	  if	  the	  composition	  of	  the	  experimental	  group	  changes	  significantly	  during	  the	  intervention	  the	  change	  may	  be	  biased	  toward	  or	  away	  from	  the	  null	  value.	  	  A	  general	  threat	  to	  construct	  validity	  also	  exists	  because	  the	  study	  includes	  only	  a	  single	  outcome	  measure.	  	  Confounding	  effects,	  such	  as	  
Page	  |	  52	  
media	  messaging	  not	  associated	  with	  the	  program,	  may	  impact	  the	  ability	  of	  the	  study	  to	  demonstrate	  causality.	  
Evaluation	  Methods	  	   I	  propose	  a	  mixed	  methods	  approach	  combining	  the	  use	  of	  quantitative	  and	  qualitative	  methods	  to	  evaluate	  the	  effectiveness	  of	  the	  program.	  	  Quantitative	  measures	  will	  be	  used	  to	  identify	  trends	  and	  provide	  answers	  to	  the	  questions	  of	  “how	  much”,	  “how	  many”	  and	  “to	  what	  extent”	  43.	  	  Program	  staff	  will	  use	  quantitative	  data	  to	  evaluate	  and	  manage	  the	  project	  implementation	  (process	  evaluation);	  this	  data	  will	  also	  enable	  coalition	  members	  and	  stakeholders	  to	  evaluate	  the	  association	  between	  the	  intervention	  and	  the	  outcomes.	  	  Qualitative	  measures	  provide	  context	  to	  the	  program	  and	  support	  the	  process	  and	  outcome	  evaluations	  by	  providing	  feedback	  on	  which	  approaches	  enhanced	  the	  program.	  	  Qualitative	  results	  can	  also	  be	  used	  to	  better	  understand	  barriers	  to	  implementation	  or	  outcomes.	  	  	  	   Quantitative	  data	  needed	  to	  evaluate	  the	  progress	  of	  the	  implementation	  will	  be	  collected	  from	  local	  physicians	  and	  entered	  into	  the	  project-­‐tracking	  database,	  which	  will	  be	  used	  by	  the	  Program	  Manager	  to	  update	  the	  project	  timeline.	  	  The	  database	  will	  include	  physician	  contact	  information,	  contact	  reports,	  training	  completion	  dates,	  follow	  up	  dates,	  and	  “to-­‐do”	  actions	  for	  each	  physician	  contact.	  	  	  Commercial	  project	  management	  software	  will	  use	  values	  generated	  from	  the	  database	  to	  update	  the	  project	  timeline	  and	  allow	  the	  PM	  to	  create	  Gantt	  charts	  suitable	  for	  reporting	  purposes.	  Regular	  updating	  of	  the	  database	  and	  project	  management	  systems	  will	  provide	  the	  program	  staff	  with	  the	  tools	  to	  manage	  the	  implementation	  and	  make	  corrections	  when	  needed.	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   Secondary	  data	  will	  be	  collected	  from	  various	  sources	  including	  the	  North	  Carolina	  State	  Center	  for	  Health	  Statistics;	  North	  Carolina	  Disease	  Event	  Tracking	  and	  Epidemiological	  Collection	  Tool	  (NC	  DETECT);	  the	  Controlled	  Substance	  Reporting	  System;	  North	  Carolina	  Office	  of	  the	  Chief	  Medical	  Examiner;	  the	  Centers	  for	  Disease	  Control	  and	  Prevention;	  and	  county	  level	  health	  assessments.	  	  This	  data	  will	  be	  used	  to	  ascertain	  morbidity	  and	  mortality	  rates	  associated	  with	  opioid	  overdose,	  and	  to	  calculate	  the	  associated	  statistics.	  	  Surveys	  will	  be	  used	  in	  the	  latter	  stages	  of	  the	  intervention	  to	  evaluate	  the	  effectiveness	  of	  the	  training	  and	  media	  communication	  efforts	  of	  the	  program.	  	   Qualitative	  data	  will	  take	  the	  form	  of	  interviews,	  face-­‐to-­‐face	  meetings,	  meeting	  notes,	  communications	  logs,	  appointment	  schedules,	  and	  other	  media.	  	  Data	  from	  these	  formats	  will	  be	  a	  combination	  of	  quantitative	  and	  qualitative,	  and	  will	  inform	  a	  great	  deal	  of	  the	  process	  evaluation.	  	  	  
Evaluation	  Planning	  Tables	  
Table	  3.	  	  Short-­‐Term	  Objective	  1:	  	  By	  month	  six,	  the	  Health	  Department	  Program	  Manager	  (PM)	  will	  assemble	  a	  working	  coalition	  of	  physicians,	  healthcare	  executives,	  public	  health	  officials,	  and	  community	  leaders.	  	  The	  assembled	  coalition	  will	  create	  a	  vision	  and	  mission	  statement	  and	  develop	  a	  set	  of	  rules	  for	  decision-­‐making	  and	  dispute	  resolution.	  
EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
Has	  the	  Program	  Manager	  
coordinated	  with	  Health	  
Department	  staff	  to	  develop	  a	  
list	  of	  prospective	  coalition	  
member	  candidates?	  
Program	  Manager	   Interviews	  with	  Health	  Department	  
staff.	  
Did	  the	  Program	  Manager	   Program	  Manager	   Communications	  logs,	  appointment	  
Page	  |	  54	  
EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
meet	  or	  talk	  with	  at	  least	  5	  
prospective	  coalition	  
candidates	  per	  week?	  
schedules.	  
Within	  six	  months	  of	  project	  
initiation	  was	  a	  working	  
coalition	  formed	  that	  included	  
a	  mix	  of	  physicians,	  community	  
leaders,	  health	  care	  officials,	  
researchers,	  and	  hospital	  
officials?	  	  
Program	  Manager,	  Coalitions	  
membership	  
Interviews,	  communications	  logs,	  
meeting	  notes.	  
Has	  the	  working	  coalition	  
established	  a	  vision	  and	  
mission	  statement	  
Program	  Manager,	  Coalition	  
membership	  
Meeting	  notes	  
Has	  the	  coalition	  established	  
protocols	  for	  decision-­‐making	  
and	  dispute	  resolution?	  
Program	  Manager,	  Coalition	  
membership	  
Meeting	  notes	  
What	  barriers	  to	  a	  cooperative	  
working	  relationship	  have	  been	  
observed	  among	  the	  coalition	  
membership?	  
Program	  Manager,	  Coalition	  
membership	  
Interviews,	  meeting	  notes	  
Describe	  the	  leadership	  style	  of	  
the	  chairperson	  of	  the	  
coalition.	  	  Is	  this	  leadership	  
style	  helping	  or	  hindering	  the	  
work	  of	  the	  coalition?	  
Program	  Manager,	  Coalition	  
membership	  
Interviews,	  questionnaires	  
How	  could	  the	  coalition-­‐	  
building	  process	  and	  the	  vision	  
mission	  development	  process	  
be	  improved?	  




Table	  4.	  	  Short-­‐Term	  Objective	  2:	  	  By	  the	  end	  of	  year	  two,	  the	  coalition	  membership	  will	  make	  contact	  with	  75%	  of	  the	  primary	  care	  physician	  practices	  and	  dental	  care	  practices	  in	  the	  county;	  50%	  of	  those	  physicians/dentists	  will	  have	  received	  opioid	  prescriber	  training,	  either	  via	  one-­‐on-­‐one	  or	  third	  party	  continuing	  medical	  education.	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EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
Did	  the	  coalition	  make	  contact	  
with	  at	  least	  75%	  of	  county	  
primary	  care	  physicians	  and	  
dentists?	  
Program	  Manager,	  program	  staff,	  
coalition	  members	  
Query	  tracking	  database	  
Did	  at	  least	  50%	  of	  physicians	  
receive	  either	  one-­‐on-­‐one	  or	  
continuing	  medical	  education	  
opioid	  prescriber	  training?	  
Program	  Manager,	  program	  staff	   Query	  tracking	  database	  
Has	  a	  physician	  contact	  and	  
tracking	  database	  been	  
developed?	  
Program	  manager,	  program	  staff	   Interviews	  
Have	  the	  coalition	  members	  
developed	  a	  plan	  to	  identify	  all	  
appropriate	  physicians	  in	  the	  
county?	  	  
Coalition	  members	   Meeting	  notes	  
Has	  the	  coalition	  created	  a	  
unified	  message	  scheme	  for	  
contacting	  physicians?	  
Coalition	  members	   Meeting	  notes	  
Did	  the	  coalition	  identify	  a	  
person	  or	  persons	  among	  the	  
coalition	  who	  would	  be	  
responsible	  for	  one-­‐on-­‐one	  
training	  of	  physicians	  in	  proper	  
opioid	  prescribing?	  
Coalition	  members	   Meeting	  notes	  
Has	  the	  database	  been	  
populated	  and	  physicians	  
assigned	  to	  coalition	  members	  
for	  contact?	  
Program	  Manager,	  program	  staff	   Query	  tracking	  database	  
Were	  physicians	  contacted,	  the	  
contacts	  documented,	  and	  
appropriate	  follow	  up	  actions	  
identified?	  
Program	  Manager,	  program	  staff	   Query	  tracking	  database	  
Describe	  the	  practices	  and	  
approaches	  that	  were	  most	  
effective	  in	  persuading	  
physicians	  to	  attend	  training	  
Program	  Manager,	  program	  staff	   Contact	  reports	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EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
What	  were	  the	  least	  effective	  
methods	  for	  contacting	  and	  
engaging	  physicians	  
Program	  Manager,	  program	  staff	   Contact	  reports	  
How	  could	  the	  process	  of	  
contacting	  physicians	  and	  
coordinating	  training	  be	  
improved?	  
Program	  Manager,	  program	  staff	   Interviews	  
 	  
Table	  5.	  	  Short-­‐Term	  Objective	  3:	  	  By	  the	  end	  of	  year	  three,	  50%	  of	  emergency	  departments	  in	  the	  county	  will	  have	  updated	  their	  opioid	  analgesic	  prescribing	  policies	  and	  procedures	  to	  reflect	  current	  best	  practices.	  
EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
Have	  50%	  of	  hospitals	  ED	  
updated	  their	  policies	  to	  reflect	  
best	  practices?	  
Program	  Manager,	  hospital	  
administrators	  
Face-­‐to-­‐face	  meetings	  
Did	  the	  coalition	  working	  group	  
review	  the	  current	  status	  of	  
hospital	  ED	  prescribing	  policies	  
in	  the	  county?	  	  
Program	  Manager,	  Coalition	  
membership	  
Meeting	  notes	  
Did	  the	  coalition	  identify	  a	  
member	  or	  members	  to	  meet	  
with	  local	  hospital	  
administrators?	  
Program	  Manager,	  Coalition	  
membership	  
Meeting	  notes	  
What	  modifications	  to	  ED	  
prescribing	  policies	  are	  
needed?	  
Program	  Manager,	  hospital	  
administrators	  
Interviews,	  meeting	  notes,	  
communications	  logs	  
What	  was	  the	  reaction	  by	  
physicians	  and	  hospital	  
administrators	  to	  the	  
emergency	  department	  
physician	  “tool	  kit”?	  
Program	  Manager	   Interviews	  
What	  was	  the	  reaction	  by	  
hospital	  administrators	  to	  the	  
program?	  
Program	  Manager,	  hospital	  
administrators	  
Interviews,	  meeting	  notes,	  
communications	  logs	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EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
How	  could	  the	  process	  of	  
updating	  ED	  prescribing	  
policies	  by	  improved?	  




Table	  6.	  	  Short-­‐Term	  Objective	  4:	  	  By	  the	  end	  of	  year	  three,	  a	  Naloxone	  rescue	  kit	  will	  accompany	  50%	  of	  new	  prescriptions	  for	  long-­‐term	  opioid	  analgesics.	  
EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
Are	  Naloxone	  rescue	  kits	  
included	  in	  at	  least	  50%	  of	  long	  
term	  opioid	  prescriptions	  in	  the	  
County	  
Physicians,	  patients	   Surveys	  
What	  were	  the	  challenges	  
encountered	  in	  the	  process	  of	  
developing	  a	  Naloxone	  rescue	  
kit?	  
Program	  Manager,	  Coalition	  
membership,	  stakeholders	  
Interviews,	  communications	  logs,	  
meeting	  notes	  
What	  was	  discovered	  while	  
testing	  the	  Naloxone	  kit	  for	  
ease	  of	  use?	  
Program	  Manager,	  Coalition	  
membership,	  stakeholders	  
Interviews	  
How	  many	  pharmacies	  in	  the	  
county	  are	  offering	  the	  rescue	  
kit	  for	  purchase?	  
Pharmacists	   Surveys	  
What	  has	  been	  the	  reaction	  by	  
healthcare	  providers	  to	  the	  
Naloxone	  rescue	  kit?	  
Local	  physician	  practices,	  clinics,	  and	  
hospitals	  
Surveys	  
Was	  a	  media	  campaign	  
implemented	  to	  communicate	  
the	  purpose	  and	  availability	  of	  
Naloxone	  rescue	  kits?	  
Stakeholders,	  Media	  organizations	   Data	  collection,	  surveys	  
How	  could	  the	  process	  of	  
introducing	  Naloxone	  rescue	  
kits	  to	  providers	  and	  the	  public	  
be	  improved?	  	  
Program	  Manager,	  stakeholders	   Interviews	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Table	  7.	  	  Long-­‐Term	  Objective	  1:	  	  By	  the	  end	  of	  year	  three,	  there	  will	  be	  a	  Countywide	  25%	  reduction	  in	  the	  overdose	  mortality	  attributable	  to	  prescription	  opioid	  analgesics.  
EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
Did	  the	  incidence	  of	  opioid	  
related	  overdose	  mortality	  
decrease	  by	  at	  least	  25%	  within	  
three	  years	  of	  project	  start	  up?	  	  
Program	  Manager,	  Coalition	  
membership,	  target	  population	  
• NC	  State	  Center	  for	  Health	  
Statistics	  
• NC	  DETECTa	  
• CSRSb	  
• NC	  Office	  Medical	  Examiner	  
• CDCc	  
Was	  a	  baseline	  mortality	  rate	  
measured	  for	  the	  target	  county	  
and	  another	  county	  in	  NC	  
(“control”)	  
Program	  Manager,	  Evaluator	   • NC	  State	  Center	  for	  Health	  
Statistics	  
• NC	  DETECTa	  
• CSRSb	  
• NC	  Office	  Medical	  Examiner	  
• CDCc	  
Was	  a	  similar	  change	  in	  
overdose	  mortality	  observed	  in	  
the	  “control”	  County	  vs.	  the	  
target	  County	  
Program	  Manager,	  Coalition	  
membership,	  stakeholders	  
• NC	  State	  Center	  for	  Health	  
Statistics	  
• NC	  DETECTa	  
• CSRSb	  
• NC	  Office	  Medical	  Examiner	  
• CDCc	  
What	  is	  the	  demographic	  
distribution	  of	  persons	  who	  
have	  died	  due	  to	  opioid	  
overdose?	  
Stakeholders	   • NC	  State	  Center	  for	  Health	  
Statistics	  
• NC	  DETECTa	  
• CSRSb	  
• NC	  Office	  Medical	  Examiner	  
• CDCc	  
Do	  disparities	  exist	  in	  the	  
overdose	  mortality	  rate	  along	  
gender,	  racial,	  or	  ethnic	  lines?	  
Stakeholders	   • NC	  State	  Center	  for	  Health	  
Statistics	  
• NC	  DETECTa	  
• CSRSb	  
• NC	  Office	  Medical	  Examiner	  
• CDCc	  
 Notes:	  a	  North	  Carolina	  Disease	  Event	  Tracking	  and	  Epidemiological	  Collection	  Tool	  b	  North	  Carolina	  Controlled	  Substance	  Reporting	  System	  c	  Centers	  for	  Disease	  Control	  and	  Prevention	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Table	  8.	  	  Long-­‐Term	  Objective	  2:	  	  By	  the	  end	  of	  year	  five,	  less	  than	  10%	  of	  victims	  who	  die	  from	  unintentional	  overdose	  will	  have	  received	  a	  prescription	  for	  a	  substance	  implicated	  in	  their	  fatal	  overdose	  from	  a	  county	  physician.  
EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
By	  year	  five	  after	  project	  start	  
up	  were	  10%	  or	  less	  of	  the	  
overdose	  victims	  receiving	  
prescriptions	  for	  opioid	  
analgesics?	  
Program	  Manager,	  coalition	  
membership,	  stakeholders,	  target	  
population	  
• NC	  State	  Center	  for	  Health	  
Statistics	  
• NC	  DETECTa	  
• CSRSb	  
• NC	  Office	  Medical	  Examiner	  
By	  the	  end	  of	  year	  five	  are	  at	  
least	  80%	  of	  physician	  practices	  
using	  safe	  opioid	  prescribing	  
practices	  as	  described	  in	  the	  
prescriber	  “tool	  kit”	  
Program	  Manager,	  physicians	   Questionnaires	  
By	  the	  end	  of	  year	  five	  are	  at	  
least	  80%	  of	  local	  hospital	  
emergency	  departments	  using	  
safe	  opioid	  prescribing	  
practices	  as	  described	  in	  the	  ED	  
“tool	  kit”	  
Hospital	  administrators	  and	  physicians	   Questionnaires	  
By	  the	  end	  of	  year	  five	  are	  the	  
majority	  of	  patients	  who	  are	  
prescribed	  opioid	  medications	  
aware	  of	  and	  using	  opioid	  
“universal	  precautions?”	  
Patients,	  physicians,	  stakeholders	   Questionnaires	  
 Notes:	  a	  North	  Carolina	  Disease	  Event	  Tracking	  and	  Epidemiological	  Collection	  Tool	  b	  North	  Carolina	  Controlled	  Substance	  Reporting	  System	  
	  
Table	  9.	  	  Long-­‐Term	  Objective	  3:	  	  By	  the	  end	  of	  year	  four,	  the	  number	  of	  physicians	  and	  pharmacists	  using	  the	  Control	  Substance	  Reporting	  System	  when	  prescribing	  or	  dispensing	  opioid	  analgesics	  will	  increase	  by	  25%.  
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EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
Has	  the	  percentage	  of	  
physicians	  using	  the	  CSRS	  
increased	  by	  25%	  four	  years	  
after	  program	  start	  up?	  




Are	  the	  majority	  of	  physicians	  
aware	  of	  the	  CSRS	  and	  how	  to	  
use	  it	  
Physicians	   Surveys	  
What	  barriers	  been	  identified	  
that	  would	  reduce	  the	  
likelihood	  of	  physician	  
utilization	  of	  the	  CSRS?	  
Program	  Manager,	  coalition	  members,	  
physicians	  
Surveys,	  Interviews	  
Among	  existing	  users	  of	  the	  
CSRS,	  how	  satisfied	  are	  they	  
with	  the	  system	  and	  do	  they	  
feel	  there	  is	  a	  benefit?	  
Physicians,	  coalition	  members,	  
stakeholders,	  NC	  DHHS	  administrators	  
Surveys	  
 Notes:	  a	  North	  Carolina	  Controlled	  Substance	  Reporting	  System	  
	  
Table	  10.	  	  Long-­‐Term	  Objective	  4:	  	  By	  year	  five,	  50%	  of	  patients	  on	  long-­‐term	  opioid	  therapy	  for	  chronic	  pain	  will	  be	  under	  the	  guidance	  of	  a	  patient-­‐prescriber	  agreement.	  
EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
Are	  50%	  of	  patients	  who	  are	  
prescribed	  extended	  
release/long	  acting	  opioids	  
under	  the	  guidance	  of	  a	  pain	  
management	  agreement	  with	  
their	  physician?	  
Patients,	  physicians,	  program	  
manager,	  coalition	  members,	  
stakeholders	  
Surveys	  
Are	  the	  majority	  of	  physicians	  
aware	  of	  the	  importance	  of	  a	  
pain	  management	  plan	  for	  
patients	  with	  long-­‐term	  chronic	  
pain?	  
Physicians,	  patients,	  program	  manager	   Surveys,	  Interviews	  
What	  barriers	  been	  identified	  
that	  prevent	  physicians	  from	  
requiring	  a	  pain	  management	  
Physicians,	  patients,	  program	  manager	   Surveys,	  Interviews	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EVALUATION	  QUESTIONS	   PARTICIPANT	   EVALUATION	  METHODS	  
plan	  for	  patients	  with	  long-­‐
term	  chronic	  pain?	  
Is	  the	  use	  of	  pain	  management	  
plans	  increasing	  or	  decreasing	  
among	  physician	  practices	  




Dissemination	  Plan	  	   Communication	  of	  evaluation	  results	  is	  a	  crucial	  component	  of	  the	  overall	  program	  plan;	  unfortunately	  findings	  are	  often	  underutilized	  because	  they	  are	  presented	  in	  a	  manner	  not	  appropriate	  for	  the	  audience.	  	  Ongoing	  evaluation	  findings	  provide	  the	  feedback	  necessary	  for	  program	  directors	  and	  staff	  to	  improve	  performance	  of	  the	  	  program49.	  	  The	  dissemination	  phase	  of	  the	  evaluation	  is	  intended	  to	  facilitate	  program	  improvement	  and	  offer	  stakeholders	  the	  information	  they	  need	  to	  provide	  continued	  support	  for	  the	  program43.	  	  The	  manner	  in	  which	  evaluation	  results	  are	  communicated	  to	  stakeholders	  is	  informed	  by	  their	  needs	  and	  may	  be	  motivated	  by	  a	  variety	  of	  political	  and	  organizational	  factors.	  	  It	  is	  incumbent	  upon	  the	  program	  staff	  to	  prepare	  and	  disseminate	  findings	  in	  manner	  that	  is	  compatible	  with	  the	  needs	  of	  various	  stakeholder	  groups.	  	  Program	  staff	  will	  consult	  with	  stakeholders	  to	  clarify	  what	  each	  user	  wants	  to	  know;	  customize	  strategies	  for	  communicating	  to	  each	  stakeholder	  group;	  ensure	  presentations	  are	  pitched	  at	  the	  proper	  level	  of	  technicality;	  and	  ascertain	  the	  preferred	  medium	  for	  presenting	  the	  findings49.	  	  Early	  and	  frequent	  consultations	  with	  stakeholders	  will	  help	  ensure	  evaluation	  results	  meet	  expectations	  and	  have	  the	  maximum	  possible	  impact.	  	  	  	   A	  summary	  of	  the	  dissemination	  plan	  is	  presented	  in	  Table	  12.	  	  The	  plan	  identifies	  four	  key	  audiences	  for	  the	  evaluation	  results:	  	  the	  program	  staff,	  coalition	  members,	  key	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stakeholders,	  media	  (i.e.,	  the	  overall	  community),	  and	  potential	  funders.	  	  Program	  staff	  and	  coalition	  members	  will	  be	  the	  most	  frequent	  users	  of	  ‘raw’	  evaluation	  findings	  and	  will	  share	  detailed	  quantitative	  results	  during	  team	  meetings	  and	  problem	  solving	  sessions.	  	  Key	  stakeholder	  groups	  such	  as	  politicians,	  community	  leaders,	  church	  groups,	  and	  hospital	  organizations	  will	  receive	  annual	  evaluation	  results	  in	  a	  variety	  of	  venues	  such	  as	  board	  meetings,	  professional	  association	  meetings,	  and	  health	  department	  meetings.	  	  Findings	  will	  be	  communicated	  to	  these	  groups	  in	  the	  form	  of	  charts,	  graphics,	  and	  other	  visual	  formats	  to	  facilitate	  rapid	  assimilation	  of	  the	  results.	  	  Media	  organizations	  such	  as	  local	  television,	  public	  radio,	  and	  print	  media	  will	  receive	  invitations	  to	  select	  public	  events	  where	  the	  program	  is	  active,	  and	  periodic	  news	  releases	  where	  appropriate.	  	  Existing	  and	  potential	  funding	  agencies	  will	  receive	  findings	  in	  the	  form	  of	  annual	  reports	  followed	  by	  formal	  presentations.	  
Table	  11:	  	  Communications	  Plan43	  
Target	  Audience	  
(Priority)	   Goals	   Tools	   Timetable	  







team	  members;	  facilitate	  
problem	  solving	  
Team	  meetings;	  ad-­‐hoc	  
gatherings	  of	  key	  staff;	  	  
Monthly	  
Key	  Stakeholders	  
	  	  	  Local	  Politicians	  
	  	  	  Community	  Leaders	  
	  	  	  Local	  Physicians	  
	  	  	  Business	  community	  
	  	  	  Hospitals	  
Promote	  program	  success;	  
establish	  ‘buy-­‐in’	  and	  
ownership	  of	  the	  program	  
One-­‐on-­‐one	  meetings;	  	  
‘Lunch	  and	  Learn’	  events;	  








evaluation	  results	  to	  the	  
community	  and	  the	  target	  
population	  
Press-­‐releases;	  social	  
media;	  invitations	  to	  
community	  events;	  	  
Annually	  and	  prior	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IRB	  and	  Ethical	  Considerations	  
Risk	  to	  Human	  Subjects	  	   Institutional	  Review	  Boards	  (IRBs)	  are	  an	  indispensible	  component	  of	  the	  evaluation	  process	  to	  ensure	  the	  protection	  and	  welfare	  of	  participants	  in	  the	  course	  of	  health	  programs	  that	  involve	  human	  subjects.	  	  Ethical	  treatment	  of	  subjects	  and	  rigorous	  protection	  of	  confidential	  information	  is	  of	  paramount	  importance	  to	  the	  success	  of	  this	  program.	  	  Although	  the	  program	  does	  not	  involve	  biomedical	  interventions	  or	  collection	  of	  information	  protected	  under	  the	  Health	  Insurance	  Portability	  and	  Accountability	  Act50,	  the	  program	  involves	  a	  public	  health	  study	  of	  behavior	  modification.	  	  Surveys	  may	  seek	  to	  obtain	  information	  regarding	  opioid	  usage	  patterns,	  understanding	  of	  opioid	  risk	  factors,	  or	  other	  behavioral	  information	  relevant	  to	  the	  evaluation	  process.	  	  Healthcare	  providers	  will	  be	  asked	  to	  attend	  interview	  sessions,	  participate	  in	  surveys,	  or	  complete	  questionnaires	  regarding	  their	  level	  of	  training	  or	  practice	  activities.	  	  This	  aspect	  of	  the	  program	  falls	  under	  the	  purview	  of	  the	  Non-­‐Biomedical	  IRB	  (Committee	  E)	  of	  the	  University	  of	  North	  Carolina	  at	  Chapel	  Hill	  IRB	  and	  Office	  of	  Human	  Research	  Ethics	  (OHRE)	  51.	  	  An	  application	  for	  IRB	  review	  and	  approval	  of	  this	  program	  will	  be	  submitted	  to	  the	  OHRE.	  	  The	  risk	  to	  humans	  subject	  participating	  in	  this	  study	  is	  comparable	  to	  that	  experienced	  in	  daily	  living	  and	  therefore	  an	  expedited	  IRB	  review	  is	  anticipated.	  	  Program	  start	  up	  will	  not	  proceed	  until	  IRB	  approval	  is	  obtained.	  	  	  
Confidentiality	  	   Protecting	  the	  confidentiality	  of	  program	  participants	  is	  an	  important	  ethical	  consideration.	  	  Consistent	  with	  the	  OHRE	  Policy	  on	  Education	  and	  Certification	  of	  Investigators	  Involved	  in	  Human	  Subjects	  Research52,	  this	  program	  is	  committed	  to	  holding	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the	  highest	  standards	  in	  research	  involving	  human	  subjects.	  	  Program	  staff,	  coalition	  members,	  evaluators	  and	  any	  other	  individuals	  involved	  with	  implementation	  or	  evaluation	  will	  be	  required	  to	  complete	  the	  Collaborative	  Institute	  Training	  Initiative	  (CITI)	  course	  in	  Human	  Subjects	  Research53.	  	  	  Completion	  of	  the	  CITI	  training	  will	  help	  ensure	  program	  staff	  and	  coalition	  members	  understand	  the	  basis	  of	  ethical	  concerns	  associated	  with	  human	  subjects	  research	  and	  comply	  with	  all	  restrictions	  associated	  thereof.	  
Discussion	  
	   A	  comprehensive,	  community-­‐based	  health	  education	  program	  targeting	  healthcare	  providers	  and	  their	  patients	  will	  help	  to	  reduce	  the	  increasing	  mortality	  and	  morbidity	  attributable	  to	  prescription	  analgesics.	  	  Until	  recently	  there	  was	  very	  little	  public	  awareness	  of	  the	  risks	  associated	  with	  prescription	  opioids,	  even	  though	  the	  negative	  effects	  associated	  with	  abuse	  of	  illicit	  opioids,	  such	  as	  heroin,	  are	  well	  established	  in	  the	  public	  lexicon.	  	  Introduction	  of	  extended	  release/long-­‐acting	  formulations	  of	  opioid	  analgesics	  in	  the	  mid	  90’s,	  combined	  with	  the	  efficacy	  of	  these	  medications	  to	  relieve	  pain	  symptoms,	  caused	  a	  rapid	  increase	  in	  market	  demand	  and	  corresponding	  increase	  in	  the	  overdose	  mortality	  rate54.	  	  A	  program	  to	  modify	  opioid	  prescribing	  practices	  and	  increase	  patient	  knowledge	  regarding	  use,	  storage	  and	  disposal	  of	  these	  medications	  is	  an	  important	  step	  toward	  addressing	  safety	  concerns.	  	   The	  systematic	  review	  illustrated	  how	  primary,	  secondary,	  and	  tertiary	  prevention	  may	  be	  used	  individually	  or	  in	  concert	  to	  reduce	  overdose	  mortality.	  	  Educating	  physicians	  in	  the	  risk	  factors	  associated	  with	  opioid	  analgesics,	  and	  offering	  them	  a	  set	  of	  guidelines	  for	  safe	  prescribing	  is	  the	  basis	  of	  primary	  prevention.	  	  Modification	  of	  hospital	  ED	  prescribing	  policies	  was	  shown	  to	  promote	  primary	  prevention	  by	  limiting	  the	  quantity	  of	  
Page	  |	  65	  
medication	  received	  by	  patients.	  	  This	  enhances	  primary	  prevention	  by	  reducing	  the	  supply	  of	  medications	  in	  circulation,	  which	  are	  susceptible	  to	  diversion	  and	  abuse	  by	  recreational	  users	  and	  patients	  alike.	  	  The	  phenomenon	  known	  as	  “doctor	  shopping”	  -­‐	  whereby	  patients	  obtain	  prescription	  medication	  from	  multiple	  prescribers	  and	  emergency	  rooms	  -­‐	  is	  addressed	  through	  the	  Controlled	  Substances	  Reporting	  System	  (CSRS).	  	  A	  form	  of	  secondary	  prevention,	  the	  CSRS	  allows	  prescribers	  to	  determine	  if	  a	  patient	  is	  soliciting	  medications	  from	  multiple	  sources.	  	  	  	   Naloxone	  rescue	  kits,	  a	  form	  of	  tertiary	  prevention,	  were	  shown	  to	  be	  effective	  in	  reviving	  patients	  who	  had	  overdosed	  and	  required	  immediate	  treatment	  for	  respiratory	  arrest.	  	  The	  two	  programs	  in	  the	  review	  that	  evaluated	  Naloxone	  rescue	  kits	  targeted	  injection	  drug	  users	  as	  their	  population	  base;	  this	  population	  differs	  significantly	  from	  the	  population	  base	  targeted	  in	  this	  study.	  	  Also,	  the	  method	  of	  Naloxone	  administration	  (intramuscular	  injection)	  differed	  from	  the	  intranasal	  method	  endorsed	  by	  the	  Project	  Lazarus	  program.	  	  	  The	  generalizability	  of	  the	  programs	  described	  in	  the	  literature	  to	  the	  population	  base	  in	  this	  study	  is	  unknown,	  and	  additional	  research	  is	  needed	  to	  demonstrate	  the	  ability	  of	  non-­‐medical	  personnel	  to	  administer	  intranasal	  Naloxone	  to	  revive	  an	  unresponsive	  patient.	  	  However,	  the	  lifesaving	  potential	  of	  Naloxone	  is	  clear	  and	  should	  remain	  an	  integral	  component	  of	  an	  overall	  approach	  to	  reducing	  overdose	  mortality.	  	  	   The	  goals	  of	  the	  program	  evaluation	  in	  this	  study	  are	  to	  ensure	  full	  implementation	  of	  the	  program	  elements,	  to	  measure	  the	  health	  impacts,	  and	  to	  provide	  the	  information	  needed	  for	  continuous	  quality	  improvement.	  	  The	  evaluation	  incorporates	  a	  quasi-­‐experimental	  design	  to	  allow	  evaluators	  to	  determine	  if	  a	  significant	  association	  exists	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between	  the	  intervention	  and	  the	  health	  impact.	  	  Establishing	  a	  causal	  association	  is	  not	  simply	  a	  matter	  of	  academic	  curiosity.	  	  If	  a	  strong	  causal	  association	  is	  established	  and	  external	  validity	  is	  demonstrated,	  the	  credibility	  and	  generalizability	  of	  the	  intervention	  is	  enhanced.	  A	  strong	  emphasis	  is	  placed	  on	  process	  evaluation,	  to	  enable	  the	  Program	  Manager	  to	  exercise	  tight	  control	  of	  the	  program	  implementation.	  	  	  Short-­‐term	  objectives	  are	  primarily	  associated	  with	  process	  evaluation	  metrics,	  which	  include	  both	  quantitative	  and	  qualitative	  measures.	  	  Quantitative	  process	  measures	  focus	  on	  time	  sensitive	  milestones	  that	  must	  be	  completed	  in	  order	  to	  move	  the	  program	  forward.	  	  Qualitative	  process	  measures	  focus	  on	  the	  effectiveness	  of	  the	  activities	  associated	  with	  implementation	  of	  the	  program,	  and	  ask	  the	  question	  “is	  this	  working,	  and	  if	  not,	  why?”	  	  The	  quantitative	  and	  qualitative	  measures	  are	  intended	  to	  allow	  the	  Program	  Manager	  and	  the	  coalition	  to	  measure	  the	  progress	  of	  the	  program	  in	  “real-­‐time”	  and	  intervene	  where	  necessary.	  	  Therefore,	  the	  process	  evaluation	  serves	  both	  as	  a	  project	  management	  and	  quality	  improvement	  tool.	  	   The	  long-­‐term	  objectives	  of	  the	  program	  evaluation	  emphasize	  the	  outcomes	  of	  the	  intervention,	  principally	  the	  effect	  on	  overdose	  mortality	  and	  the	  causal	  factors	  thought	  to	  be	  associated	  with	  the	  primary	  outcome.	  	  As	  with	  the	  process	  evaluation,	  quantitative	  and	  qualitative	  measures	  are	  used	  to	  document	  the	  health	  outcomes	  and	  the	  factors	  that	  are	  important	  to	  sustaining	  the	  intervention.	  	   Leadership	  is	  the	  most	  important	  element	  of	  this	  program55.	  	  The	  literature	  shows	  that	  a	  community-­‐based	  intervention	  to	  reduce	  overdose	  mortality	  can	  be	  a	  powerful	  tool	  to	  prevent	  unnecessary	  death,	  and	  this	  program	  and	  evaluation	  plan	  describes	  how	  such	  a	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program	  may	  be	  implemented.	  	  	  However,	  without	  the	  driving	  force	  of	  a	  strong	  leader	  to	  advance	  the	  program	  at	  the	  local	  level,	  the	  intervention	  will	  not	  move	  forward56,57.	  	  The	  widely	  disparate	  organizations	  and	  community	  groups	  the	  form	  the	  coalition	  must	  be	  formed	  into	  a	  cohesive	  group	  with	  a	  singular	  mission.	  	  This	  will	  not	  occur	  without	  the	  impetus	  of	  a	  committed	  leader	  with	  a	  clearly	  vision	  and	  the	  strength	  to	  articulate	  that	  vision	  to	  the	  community.	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Appendix	  	  
Table	  1:	  	  Community	  Based	  Opioid	  Prevention	  Programs	  	  
Program	  Name	   Year	   Goal	  
Similar	  	  
Elements	   Implementation	   Evaluation	   Outcomes	  
Project	  Lazarus	   2009-­‐Present	   Reduction	  in	  unintentional	  
poisoning	  mortality	  rate	  
	  1,2,3,4,5	   • Community	  organization	  
and	  activation.	  
• Prescriber	  education	  and	  
behavior	  modification.	  
• Supply	  reduction	  and	  
diversion	  control.	  
• Pain	  patient	  services	  and	  
drug	  safety.	  
• Drug	  treatment	  and	  
demand	  reduction.	  
• Harm	  reduction.	  
• Community-­‐based	  
prevention	  education.	  
Community	  activation	  and	  
coalition	  building.	  
• Central	  community	  
organizer	  established.	  
• Community	  boards	  
active	  in	  directing	  
change.	  
	  
Monitoring	  and	  Surveillance	  
• Overdose	  mortality	  rate.	  
• Number	  of	  overdose	  
patients	  who	  received	  a	  
prescription.	  
	  
Prevention	  of	  overdose	  
• Health	  Department	  visits	  
to	  providers.	  
• Development	  of	  took	  kit.	  
• Percentage	  of	  providers	  
registered	  with	  CSRS1	  
	  
Community	  activation	  and	  
coalition	  building.	  
• Central	  community	  
organizer	  established.	  
• Community	  boards	  active	  
in	  directing	  change.	  
	  
Monitoring	  and	  Surveillance	  
• Overdose	  mortality	  
dropped	  from	  43	  per	  
100,000	  in	  2008	  to	  29	  per	  
100,00	  in	  20102.	  
• In	  2008	  82%	  of	  decedents	  
received	  a	  prescription	  
for	  an	  implicated	  
substance	  dropping	  to	  
10%	  in	  2010.	  
	  
Prevention	  of	  overdose	  
• Health	  department	  
Medical	  Director	  visited	  
with	  70%	  of	  office	  
practices	  in	  Wilkes	  
County.	  
• Took	  kit	  developed	  for	  
local	  primary	  care	  
providers.	  
• 70%	  of	  Wilkes	  County	  
providers	  registered	  with	  
CSRS	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Controlled	  Substance	  Reporting	  System.	  2	  Wilkes	  County,	  North	  Carolina	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Program	  Name	   Year	   Goal	  
Similar	  	  
Elements	   Implementation	   Evaluation	   Outcomes	  
Provider	  Detailing	   2008	   Decrease	  deaths	  related	  to	  
prescription	  opioids	  in	  Utah	  
3,	  5	   • Physician	  education	  in	  the	  
“Six	  practices	  for	  safe	  
opioid	  prescribing”	  and	  
the	  Utah	  guidelines	  for	  
safe	  prescribing	  of	  opioids.	  
• Presentation	  materials.	  
	  
Process	  Evaluation.	  
• Number	  of	  physicians	  
attending	  presentations	  
• %	  Surveys	  returned	  @	  0,	  
1	  &	  6	  months.	  
	  
Outcome	  Evaluation	  
• %	  Physicians	  aware	  of	  
six	  practices/guidelines.	  
• %	  Physicians	  adopting	  
six	  practices.	  
• %	  Physicians	  using	  
controlled	  substance	  
database	  
• %	  Physician	  referring	  for	  
sleep	  studies/EKG	  




• %	  Reduction	  in	  mortality	  
from	  unintended	  




• Total	  581	  (%	  unknown)	  
• 366	  surveys@	  0	  months	  
• 82	  surveys@	  1	  month	  
• 29	  surveys@	  6	  months	  
	  
Outcomes	  
• 85%	  Physicians	  aware	  of	  
six	  practices	  
• 60%	  -­‐	  80%	  Physicians	  
adopting	  six	  practices.	  
• 50%	  Physicians	  using	  
controlled	  substance	  
database	  
• 30%	  -­‐	  50%	  Physicians	  
referring	  for	  sleep	  




14%	  reduction	  in	  mortality	  
from	  unintended	  overdose	  




2004	   Reduce	  mortality	  due	  to	  
opioid	  overdose	  among	  
injection	  drug	  users	  in	  New	  
York	  City	  
2,	  4,	  5	   • Volunteer	  participants	  
receive	  1-­‐hour	  training	  in	  
overdose	  recognition,	  and	  
response	  including	  
Naloxone	  administration.	  
• Baseline	  survey	  and	  
participants	  receive	  pre-­‐
loaded	  Naloxone	  syringes	  
• Participants	  survey	  follow	  
up	  at	  3	  months.	  
	  
Process	  Evaluation.	  
• Participants	  recruited	  
from	  LESHRC	  
• Training	  completed	  
• Follow	  up	  at	  3	  months.	  
	  
Outcome	  Evaluation	  
• Patient	  assessed	  
• EMS	  activated	  
• Medication	  delivered	  
	  
Impact	  Evaluation	  
• Resuscitation	  successful.	  
	  
Process	  Evaluation.	  
• 25	  Participants	  recruited	  
from	  LESHRC	  
• 100%	  completed	  training	  
• 88%	  follow	  up	  rate	  @	  3	  
months.	  
Outcome	  Evaluation	  
• 17	  witnessed	  overdoses	  
• 82%	  EMS	  activated	  
• 58%	  Naloxone	  
administered.	  
Impact	  
• 100%	  of	  patients	  
administered	  Naloxone	  
survived.	  
Page	  |	  78	  
Program	  Name	   Year	   Goal	  
Similar	  	  
Elements	   Implementation	   Evaluation	   Outcomes	  





Ensure	  risks	  of	  extended	  
release/long-­‐acting	  opioid	  
analgesics	  are	  addressed	  
and	  managed	  
2,3,5	   • Drug	  manufacturers	  
create	  Patient	  Medication	  
Guide	  
• Physician	  Education:	  
Elements	  to	  Assure	  Safe	  
Use	  (ETSAU)	  
• Timetable	  for	  Assessment	  
Process	  Evaluation.	  
• Patient	  Medication	  
Guide	  created	  and	  
distributed	  to	  
prescribers	  
• Physician	  training	  
curriculum	  developed	  
and	  physicians	  trained	  
• Assessment	  plan	  
developed	  and	  reports	  
issued	  at	  18	  months,	  3	  









Training	  Program	  for	  
Injection	  Drug	  Users	  
in	  Los	  Angeles	  
2006-­‐2008	   Reduce	  mortality	  due	  to	  
opioid	  overdose	  among	  
injection	  drug	  users	  in	  Los	  
Angeles,	  California	  
3,4,5	   • Volunteer	  participants	  
receive	  1-­‐hour	  training	  in	  
overdose	  recognition,	  and	  
response	  including	  
Naloxone	  administration.	  
• Baseline	  survey	  and	  
participants	  receive	  pre-­‐
loaded	  Naloxone	  syringes	  
• Participants	  survey	  follow	  
up	  at	  3	  months.	  
	  
Process	  Evaluation.	  
• Participants	  recruited	  
from	  LESHRC	  
• Training	  completed	  
• Follow	  up	  at	  3	  months.	  
	  
Outcome	  Evaluation	  
• Participants	  increase	  
knowledge	  of	  overdose	  
and	  Naloxone?	  
• Improved	  attitudes	  
toward	  overdose	  
response	  and	  EMS	  
activation?	  
• Increased	  frequency	  of	  
recommended	  response	  
behaviors?	  




• 66	  Participants	  recruited	  
from	  HHCLA-­‐HRC	  
• 100%	  completed	  training	  




• Improved	  knowledge	  of	  
overdose	  and	  Naloxone	  
(P<0.0001)	  
• No	  change	  in	  attitudes	  
toward	  overdose	  
response	  or	  EMS	  
activation	  
• Increased	  frequency	  of	  
recommended	  response	  
(P<0.01)	  
• Decrease	  in	  non-­‐
recommended	  behavior.	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Figure	  1:	  Overdose	  Prevention	  Program	  Logic	  Model
Outcomes	  and	  Impact	  Outputs	  Activities	  Inputs	  Assumptions	  
People:	  
• Health	  Directors	  
• Primary	  care	  physicians	  
• Patients	  and	  families	  
• Health	  educators	  




• State	  of	  NC/	  Kate	  B.	  




• Local	  Health	  
Department	  
• Physician	  Practices	  
• Hospitals	  
• Chronic	  Pain	  Advisory	  
Workgroup	  
• Community	  Care	  North	  
Carolina.	  
• Project	  Lazarus	  
• Community	  Coalition	  
	  
Materials	  &	  Resources:	  
• Prescriber	  Tool	  Kit	  
• Emergency	  Department	  
tool	  kit	  
• Naloxone	  rescue	  kit	  	  
• Identify	  and	  recruit	  
stakeholders.	  
• Assemble	  a	  working	  
coalition.	  
• Create	  vision/mission.	  




• Assemble	  provider	  and	  ED	  
tool	  kits	  
• One-­‐on-­‐one	  provider	  
education	  on	  pain	  
management	  
• Continuing	  medical	  




• Hospital	  ED:	  update	  opioid	  
dispensing	  policies	  
• Promote	  CSRS	  
• Licensing	  actions	  against	  
rogue	  providers	  
• Naloxone	  prescription	  for	  
high	  risk	  patients	  
• Detox	  program	  
• School	  based	  education	  
• Media	  messaging	  
	  
• Increased	  













• Families	  have	  a	  tool	  




messaging	  to	  the	  
community	  
	  
Short	  Term	  Outcomes	  (1-­‐3	  
years)	  
• Physicians	  and	  hospital	  
EDs	  using	  opioid	  
therapy	  best	  practices	  
• Community	  members	  
using	  opioid	  “Universal	  
Precautions”	  
• Naloxone	  rescue	  kit	  
usage	  increasing.	  
Impact	  (3	  -­‐	  5	  +	  years)	  
• Fewer	  overdose	  incidents	  
from	  licit	  or	  illicit	  use	  of	  
prescription	  opioids.	  
• Access	  to	  opioids	  for	  
legitimate	  users	  not	  
resctricted.	  
Sales	  of	  opioid	  analgesics	  
have	  increase	  more	  than	  





attributable	  to	  opioid	  
analgesics	  have	  
quadrupled	  in	  North	  
Carolina,	  from	  3.5	  deaths	  
per	  100,000	  in	  1999	  to	  
11.0	  deaths	  per	  100,000	  
in	  2009.	  	  Nationally	  
overdose	  deaths	  now	  
exceed	  deaths	  from	  
motor	  vehicle	  accidents.	  
 
Overdose	  deaths	  in	  
Wilkes	  County,	  NC	  spiked	  
to	  49	  deaths	  per	  100,000	  
in	  2007;	  in	  response	  a	  
community-­‐based	  
intervention	  was	  
implemented.	  	  By	  2010	  






patient	  awareness,	  harm	  
reduction,	  and	  diversion	  
control	  will	  reduce	  
mortality	  rates.	  
	  
Table	  2:	  Program	  Timeline	  	  
Activity	   Responsible	  Party	   Timeline	  
Appoint	  Program	  Manager	  
	   Health	  Department	  Director	   Month	  1-­‐2	  
Submit	  IRB	  application	   Program	  Manager	   Month	  2	  
Submit	  grant	  application	  to	  Kate	  B.	  Reynolds/NC	  DHHS	  for	  program	  
funding	   Program	  Manager	   Month	  2	  
Recruit	  and	  assemble	  coalition	  membership	   Program	  Manager	   Month	  2-­‐4	  
Establish	  Vision/Mission	  Statements;	  Agree	  on	  processes	  for	  decision	  
making	  and	  dispute	  resolution	  
Program	  Manager	  and	  coalition	  
membership	   Month	  4-­‐6	  
	  
Create	  project	  tracking	  database;	  add	  contact	  information	  for	  all	  
providers	  in	  the	  County	  
	  
Program	  Manager,	  Administrative	  
Assistant,	  or	  coalition	  member	  with	  
IT	  expertise	  
Month	  4-­‐6	  
Coordinate	  with	  third	  party	  continuing	  education	  providers	   Program	  Manager	   Month	  4-­‐6	  
Select	  trainers	  from	  coalition	  for	  one-­‐on-­‐one	  provider	  education	   Coalition	  membership	   Month	  6-­‐8	  
Assemble	  provider	  and	  emergency	  department	  tool	  kits,	  Naloxone	  
rescues	  kits	  and	  training	  materials	   Administrative	  Assistant	   Month	  4-­‐6	  
Assign	  contact	  person(s)	  for	  each	  provider	  and/or	  hospital	  administrator	   Program	  Manager,	  Coalition	  membership	   Month	  6-­‐8	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Initiate	  contacts	  with	  providers;	  schedule	  one-­‐on-­‐one	  training	  sessions	  or	  
coordinate	  continuing	  education	   Coalition	  membership	   Month	  6-­‐12	  
Develop	  “model”	  emergency	  department	  opioid	  prescribing	  policies	   Coalition	  membership	   Month	  8-­‐12	  
Conduct	  provider	  training	   Trainers,	  third	  party	  continuing	  education	  organizations	   Month	  6-­‐24	  
Process	  Evaluation	   Program	  Manager,	  Third	  Party	  Evaluator	   Year	  1	  
Outcome	  Evaluation	   Program	  Manager,	  Third	  Party	  Evaluator	   Year	  2	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Figure	  3:	  Program	  Annual	  Budget	  	  
Personnel	  
	   	  	  	   Program	  Manager	   $55,000	  	  
	  
Administrative	  Aide	  (25%)	   $10,000	  	  
	  	   Benefits	  @	  25%	   $16,250	  	  
Personnel	  Total	   $81,250	  	  
	   	   	  Equipment	  &	  Supplies	  
	  	  	   Laptop	  Computer	   $1,500	  	  
	  	   Projector	   $750	  	  
Total	  Equipment	  &	  Supplies	   $2,250	  	  
	   	   	  General	  Office	  
	  	  	   Postage	   $750	  	  
	  
Cell	  Phone	   $960	  	  
	  
Printing	  &	  Binding	   $3,000	  	  
	  	   General	  Office	  Supplies	   $500	  	  
General	  Office	  Total	   $5,210	  	  
	   	   	  Travel	  &	  Transportation	  
	  	  	   Airfare	  (2	  round	  trip	  airfare)	   $1,500	  	  
	  
Lodging	  (10	  days)	   $1,750	  	  
	  
Mileage	  	   $1,100	  	  
	  	   M&IE	  (10	  days	  @	  $75/day)	   $750	  	  
Travel	  &	  Transportation	  Total	   $5,100	  	  
	   	   	  Training	  &	  Consulting	  
	  	  	   Training	  Services	   $5,000	  	  
	  	   Program	  Evaluation	  Services	   $10,000	  	  
Training	  &	  Consulting	  Total	   $15,000	  	  
	   	   	  Miscellaneous	  
	  	  	   Food	  and	  Refreshments	   $2,000	  	  
	  	   Conference	  Room	  Rental	   $1,000	  	  
Miscellaneous	  Total	   $3,000	  	  
	  
Total	  Expenditures	  Year	  1	   $111,810	  	  	  
